LEUKEMIA LYMPHOMA MYELOMA

2005 Annual Report our mission

Cure leukemia, Over its history, the Society has been the recognized leader in the fight against leukemia. Our name change to The Leukemia & Lymphoma lymphoma, Society in 2000 was simply perception catching up to reality. The Hodgkin’s Society’s objective is to find cures for all blood cancers, and to be disease and the leading resource for patients battling all of these cancers. myeloma, and This year, the Society took the first step in making access to specific improve the information and services simpler for patients with these cancers. quality of life We developed a color-coding system for the three main categories of blood cancers: Our new signature colors are green for leukemia, of patients and gold for lymphoma and blue for myeloma. Any information that their families. is relevant to all the diseases is coded burgundy. All print materials prepared for patients during this year reflect the new system, making access to important information and resources more efficient. You’ll also see our new colors in such e-newsletters as LeukemiaLinks, LymphomaLinks and MyelomaLinks.

The next step will be to extend the new system to other venues, including access to information on the Society’s Web site.

This year’s Annual Report displays the new colors with pride. They represent the ongoing efforts to constantly improve on the ways

the Society serves and supports patients and those who love and 2 005 | care for them. AN N U AL R EPOR T leadership message

We are fortunate to be able to report that fiscal year 2005 was a banner year for the Society in many ways. Let’s start with revenue. The Society raised $218.6 million through private donations, corporate gifts and our various fundraising campaigns – that’s $38 million more than we raised in fiscal 2004. Our already successful campaigns such as Team In Training® and Light The Night® Walk were even more productive in fiscal 2005 (for information on individual campaigns, please turn to pages 12 and 13 of this report). And our donor development initiatives have shown impressive growth – a 38 percent increase in revenue over last year, to more than $25 million in fiscal 2005.

The big story of the year is not just our success as fundraisers, but also our success as prudent stewards. Since its founding in 1949, the Society has been steadfast in pursuing its mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. In fiscal 2005, we were able to strengthen our commitment, supporting four new Specialized Center of Research (SCOR) grants and renewing two others – for a total of six SCORs awarded in the fiscal year, a Society record. More money for the best research globally means more research successes; and more research successes mean greater hope for the hundreds of thousands of patients battling leukemia, lymphoma and myeloma.

Finally, The Leukemia & Lymphoma Society of Canada became part of the Society effective July 1, 2004, and this year’s annual report is the first to include our Canadian operations. We are pleased to be serving the needs of patients and families in Canada as well as in the United States.

Until the day comes when we can finally say we’ve defeated blood cancers, the Society will be here to help guide patients and their families on the cancer journey. In fiscal year 2005, the Society had 2.5 million contacts with patients, caregivers and healthcare professionals, through our Web site, Information Resource Center, education programs and chapter-based outreach.

Yes, we made great progress in advancing our mission in fiscal 2005, thanks to the dedicated volunteers, employees, donors and researchers who helped make the year so successful. We are looking forward to doing even more in fiscal 2006! 2 005 |

Dwayne Howell John M. Kamins AN President & CEO Chairman N U AL R EPOR T

2 3

patient services In 2005, the Society offered new educational and support 2005 leukemia programs and services to meet the needs of patients battling AML, CML, ALL and CLL. highlights A small sample of new Society programs, services and materials follows: research I New Approaches to CLL: The Changing Treatment Landscape, featured world-renowned hematologist/ In the fight against blood cancers, leukemia research to Gleevec experienced a complete hematological oncologist Michael Keating, M.D., The University has arguably led the way, with major innovations in remission. Dr. Sawyers, a SCOR team leader, credited of Texas M.D. Anderson Cancer Center. A better the development and testing of targeted therapies earlier Society-funded research on Gleevec resistance understanding of how leukemia cells work and grow in just the past five years. Gleevec®, the first product with his ability to move ahead with recent, highly has led to targeted therapies for individual patients, of this research, was only the beginning. This Society- successful clinical trials. and more refined diagnostic tests have enabled doctors funded breakthrough has led to additional studies that I Varsha Gandhi, Ph.D., The University of Texas M.D. to devise smarter treatment strategies for all patients. are further advancing treatment options for patients with Anderson Cancer Center, received a Translational In this program, Dr. Keating discussed the latest news chronic myelogenous leukemia (CML) and for those Research Program (TRP) grant from the Society about CLL, as well as clinical trials that might lead battling acute myelogenous leukemia (AML) and acute for her work, DNA Independent Strategy to Target to even better treatments in the future. and chronic lymphocytic leukemia (ALL and CLL). CLL. Many types of leukemia are caused by increased They include: I Medical Update on AML: New Treatments and Blood cell proliferation and are frequently treated with drugs Stem Cell Transplantation, was jointly presented by the I The Society funded a new Specialized Center of that target DNA. In contrast, CLL expansion is more Society, the National Bone Marrow Donor Program and Research (SCOR) grant, Targeted Inhibition of often associated with decreases in leukemic cell death. CancerCare. The program featured Selina Luger, M.D., Oligomeric Translocation Products in AML, CML and Dr. Gandhi’s research focuses on a chemotherapeutic University of Pennsylvania Cancer Center, who presented ALL, led by John Bushweller, Ph.D., the University of agent called chlorinated adenosine (8-CI-Ado), an overview of AML; and J. Douglas Rizzo, M.D., Medical Virginia. The five-year project will focus on new which has been shown to cause CLL cell death in College of Wisconsin, who discussed treatment options, therapies for Gleevec-resistant CML patients and laboratory models by decreasing energy stores and including marrow and blood stem cell transplantation. AML and ALL patients who do not respond to the production of new RNAs, both critical to cell standard therapies. This SCOR expands on current survival. Dr. Gandhi will now study what happens I CML: Ask the Expert, a telephone education program, knowledge about the specific genetic defects that when 8-CI-Ado is introduced into fresh peripheral, featured Stephen D. Nimer, M.D., head of the Division create malignancies in blood cells that harbor them, (circulatory) blood cells obtained from patients of Hematologic-Oncology, Memorial Sloan-Kettering and on the successful application of Gleevec to with CLL. The objective is to advance this agent Cancer Center. The entire one-hour session was devoted many patients with CML. to clinical trials. to Dr. Nimer fielding questions from the audience, a format of great value to participants. I Charles Sawyers, M.D., UCLA School of Medicine, presented findings at the 46th Annual Meeting I New Discoveries in CML: This teleconference featured of the American Society of Hematology (ASH) for two distinguished experts from M.D. Anderson: Francis J. a new agent, BMS-354825. In clinical trials of this Giles, M.B., M.D., F.R.C.P.I., F.R.C.Path, professor of agent, 86 percent of early-stage CML patients resistant medicine, Department of Leukemia; and Moshe Talpaz, M.D., professor of medicine, Department of Experimental Therapeutics. They discussed the latest information on CML therapies and the future direction of CML We’re currently testing a new agent, hunter’s story research, and they answered questions from the BMS-354825, in clinical trials among On the Friday afternoon when the doctor audience about CML clinical trials, newer treatments “ and other topics of interest. CML patients resistant to Gleevec, and it shows announced that our 10-month-old son had “leukemia, I was very frightened even though I An updated booklet, Acute Lymphocytic Leukemia, tremendous promise for getting patients I wasn’t 100 percent sure what leukemia was. provides information on this cancer, current treatments, 2

into complete hematological remission. It was a great reassurance when, by Monday new research directions and emotional aspects 005 | Earlier Society-funded research afternoon, the Society had contacted our home of managing the disease.

and was helping us cope with the diagnosis. They AN we did on Gleevec resistance

followed up regularly and continued to supply N

enabled us to get to this point. information as my son’s situation changed. U AL R

Charles Sawyers, M.D., UCLA School of Medicine” • Lori Ruderman, mother of 6-year-old Hunter, ” EPOR leukemia survivor. T

4 5

2005 lymphoma highlights vaithee’s story The Society has helped us in so many ways — research from financial support for expenses not covered patient services “by health insurance to tickets to baseball games Below are just three examples of outstanding against tumor cells. Ongoing studies in mice to keep our spirits up. Through the First Connection A number of new educational and support programs Society-sponsored lymphoma research, including will determine how these proteins function program I was able to talk to someone who is were developed this year to answer the needs of laboratory studies, clinical trials and a collaborative in the immune system. Results will likely help living healthy and cancer free. That was a great patients battling Hodgkin and non-Hodgkin lymphoma. Specialized Center of Research (SCOR) project, all of in the development of a new class of molecularly morale booster in a dark time. which will help advance the search for cures. targeted drugs for patients with lymphoma A small sample of new programs follows: and leukemia. • Subramanian “Vaithee” Vaitheeswaran, I I A SCOR grant was awarded to Tak Mak, Ph.D., ” Information for the Newly Diagnosed: A Patient’s non-Hodgkin lymphoma survivor. Advanced Medical Discovery Institute, University Guide is part of our ongoing program, Insights of Toronto, for a five-year project, Signaling Into NHL, a year-long series of teleconferences Pathways in Lymphoma and Leukemogenesis. and newsletters for non-Hodgkin lymphoma (NHL) These collaborative studies will increase our patients and families. This telephone education understanding of lymphoma and leukemia program featured Andrew Zelenetz, M.D., chief, processes and direct the development of new Lymphoma Service, Memorial Sloan-Kettering anti-cancer agents and clinical trials. Dr. Mak Cancer Center. Dr. Zelenetz explained the importance and his team will identify how genetic defects of diagnosing the sub-type of lymphoma and in blood stem cells cause the formation of rare determining its location(s) in the body, stage of cancer stem cells that expand to form lymphomas development and other factors to ensure the best and leukemias. treatment. Clinical trials also were discussed, and Dr. Zelenetz answered questions from the audience. I A Translational Research Program (TRP) grant to I Alain Rook, M.D., University of Pennsylvania, was Meet the Expert on Non-Hodgkin Lymphoma was renewed this year for his ongoing investigation into updated this year and offered at chapters across promising new therapies for patients with T-cell the nation to share new information on NHL with malignancies. Dr. Rook and his team discovered patients at the community level. This informative that immune system cells in patients with program featured local lymphoma experts and extensive cutaneous T-cell lymphoma (CTCL) were cancer-care professionals. typically not producing a molecule called CD40L, I Emerging Therapies for Orphan Lymphomas: rendering them unable to attack and kill Cutaneous T-Cell, Peripheral T-Cell, Mantle Cell, lymphoma cells. In the laboratory, synthetic CD40L Mucosa-Associated Lymphoid Tissue (MALT) and markedly improved immune cell anti-lymphoma Waldenström’s Macroglobulinemia, a teleconference, activity. Dr. Rook’s new study, CD40 Ligand Defect featured Francine Foss, M.D., Ph.D., F.A.C.P., associate in Cutaneous T-Cell Lymphoma, will investigate professor of medicine, director, Lymphoma Service, the cellular and molecular reasons for the Tufts New England Medical Center; David J. Inwards, CD40L effect with a goal of administering the Thanks to our Society SCOR grant, M.D., assistant professor of medicine, practice chair, new drug in clinical trials to treat patients with we’re able to develop customized Hematology, Mayo Clinic College of Medicine; and advanced CTCL. “ Morie A. Gertz, M.D., professor of medicine, division lymphoma vaccines that we hope will trigger I Weiguo Zhang, Ph.D., Duke University Medical chair, Hematology, Mayo Clinic College of Medicine. Center, received a Career Development Program an immune response specifically These “orphan” lymphomas (meaning that they affect fewer people than the more common types of this 2 (CDP) grant for a study titled Adaptor Proteins against an individual’s tumor. 005 | in Lymphocyte Activation. The research studies two cancer) were explained along with the latest treatment This will make the first treatment advances and clinical trials. molecules, LAT and LAB, found in certain immune AN the best treatment for that patient. cell (lymphocyte) membranes. These molecules N U

were shown in previous studies to be essential AL Ronald Levy, M.D., Stanford University School of ”Medicine

for the lymphocyte activation and development R that is needed for effective immune responses EPOR T

6 7

patient services The Society provided several new myeloma resources this year. These are just a few of the 2005 myeloma Society’s programs and services for myeloma highlights patients, their families and caregivers: I The Latest News About Myeloma featured renowned hematologist Seema Singhal, M.D., research director, Multiple Myeloma Program, Northwestern Three new, Society-funded research programs are I Jing Chen, Ph.D., Emory University, received a University Medical School/Robert H. Lurie examples of current efforts in the search for improved Career Development Program grant for Molecular Comprehensive Cancer Center. She shared her therapies and cures. Therapeutic Strategies in Multiple Myeloma: optimism about the future of treatment for this Targeting FGFR3. This study is likely to provide cancer and provided updates on new therapies I A Translational Research Program (TRP) grant was information about the role of the protein FGFR3 in and combination treatments, clinical trials, genetic renewed this year for David Avigan, M.D., Beth Israel causing multiple myeloma. The research may also testing and other factors that are dramatically Deaconess Medical Center. In previous studies, whole provide new strategies to improve treatment changing the landscape for myeloma patients. myeloma tumor cells and normal immune cells, both outcomes, since about 15 percent of myeloma taken from a patient, were fused, and these fused I Exploring Myeloma was launched to provide patients have a genetic abnormality that causes cells were used to stimulate (immune) T cells to patients with a new educational resource. Led inappropriate FGFR3 expression. recognize and kill myeloma cells from the same by local blood cancer experts, Exploring Myeloma patient. In his new study, Vaccination with Dendritic presents a thorough overview of the cancer in Cell Tumor Fusions in Conjunction with Stem Cell an easy-to-follow, one session, classroom format. Transplantation as a Novel Immunotherapy for The program, piloted this year in seven Society Multiple Myeloma, Dr. Avigan will conduct clinical trials chapters, includes a one-hour slide presentation, in which stem cell transplant patients with myeloma followed by an hour-long Q&A with the experts. will be immunized with a customized fusion vaccine Exploring Myeloma also examines the emotional to determine whether these vaccines will improve and social aspects of a myeloma diagnosis. chances for patient survival. It is being offered at all Society chapters in 2006. I Lawrence Lum, M.D., Roger Williams Medical I Two new educational booklets were created Center, received a TRP grant for a project called this year: Myeloma provides a comprehensive Circumventing Rituximab Resistance in Patients with overview of the cancer, with segments on the B Cell Malignancies. Dr. Lum will study the effects disease, how it’s detected, treatment options of a molecule he created, CD20Bi, on myeloma and and what the future for this disease may hold, lymphoma cells. The molecule links a drug used to based on today’s research. Social and emotional fight these cancers, rituximab, with a patient’s own aspects are also explored. Myeloma: A Guide T cells. Dr. Lum’s new research will determine whether for Patients and their Families gives information patients who are resistant to rituximab can benefit on how to help manage this cancer from diagnosis from multiple infusions of their own rituximab-armed through treatment. immune cells, following chemotherapy and stem cell transplantation. If successful, this clinical study will improve survival and decrease relapse rates for myeloma and lymphoma patients. judy’s story I began suffering from health issues in 1999, but it took two years of specialists and complicated Our Translational Research Program grant “tests to come up with the devastating diagnosis: from the Society is helping us conduct multiple myeloma. Thankfully, the Society was

“ 2 there, helping me make informed decisions about

clinical trials of patients with B cell malignancies 005 | my care and making it easier for me to explain who are resistant to rituximab. myeloma to my concerned friends and family. If we’re successful, we’ll be able to arm patients’ AN

• Judy Dixon, myeloma survivor N

” U T killer cells with the targeting antibodies AL

and improve their survival and decrease relapse. R EPOR

Lawrence Lum, M.D., Roger Williams Medical Center ” T

8 9

2005 blood cancer highlights research to help them communicate more effectively with healthcare professionals. The Comprehensive Geriatric In addition to funding research focused on specific stem cell harvests. Dr. Scadden and his colleagues Assessment, a checklist to help oncologists evaluate blood cancers, the Society invests in research that holds will test the effect of PTH on the number of adult older patients’ capacity to undergo treatment and side promise for finding cures and improved therapies across blood stem cells in a mouse transplant model and in effects, was introduced as part of this program. the entire blood cancer spectrum. The following are human patients. If PTH treatment increases the stem I Also published this year is A Toolkit for Older examples of important studies: cell recovery rate, it could be used to improve the Adults with Cancer and Their Caregivers, which successful application of stem cell transplants for I Jose Villadangos, Ph.D., Walter & Eliza Hall Institute includes booklets on choosing a healthcare team, hematologic malignancies. of Medical Research, received a Career Development understanding treatment options, clinical trials and Program (CDP) grant to study the Control of Antigen I David Weinstock, M.D., Memorial Sloan-Kettering financial matters; and a guide to help caregivers Presentation, Cross-Presentation and Migration in Cancer Center, received a CDP grant to study understand the ins and outs of their important role. Dendritic Cells. He is studying one way in which our the chromosomal breakage and exchange that I Cognitive and Late Effects Related to Childhood immune system can fight cancer. This involves results in an abnormality called a “translocation,” Cancer is a teleconference education program anti-cancer “killer” T cells that are recruited by other commonly found in various types of blood cancers. featuring Daniel Armstrong, Ph.D., University of Miami immune system cells known as dendritic cells (DC). The Chromosomal Translocations after RAG-Mediated School of Medicine. In this program, Dr. Armstrong These cells take parts of cancer cells, break them into DNA Double Strand Breaks project is aimed at discusses new research on the potential long-term smaller pieces and display these pieces to the killer understanding how chromosome breaks occur and effects of cancer treatment on a child’s ability to learn cells, which recognize them. The killer cells then seek how normal cells repair them. Using a novel system and, eventually, to work and participate in social and destroy other, related cancer cells. However, they have developed, Dr. Weinstock and his group relationships. The potential effects of chemotherapy cancer cells sometimes avoid detection by dendritic will determine which proteins prevent and which and radiation therapy were discussed, along with cells, and then a tumor can expand. To get around this ones facilitate translocation formation. In addition, some of the educational and pharmaceutical limitation, Dr. Villadangos will obtain dendritic cells they will study how chemotherapies for various measures being used to address cognitive problems from patients and put them in the test tube with human cancers can promote translocation formation, that can result from cancer treatment. The special cancer cell pieces to generate “DC vaccines.” The producing secondary blood cancers. The ultimate goal needs of these children with respect to individualized vaccines can then be re-introduced to patients to of this project is to be able to prevent chromosome education plans were also addressed. activate anti-cancer killer cells. He will learn how the translocations and block blood cancer formation. dendritic cells obtain the cancer cell pieces, process them and display them on their surfaces. This knowledge is likely to improve methods for generating patient services advocacy DC vaccines that will have broad applications in In addition to disease-specific information and services, Advocates for blood cancer patients faced many anti-cancer therapies. the Society provides resources of relevance and interest The Society’s free information programs and legislative challenges in 2005, but the Society was I David Scadden, M.D., Massachusetts General Hospital, to all blood cancer patients. This is a small sample services for blood cancer patients, their families ready, scoring some notable successes for cancer received a Translational Research Program grant for of programs and materials made available this year: and caregivers are accessible in a variety research and education. the study Therapeutic Manipulation of the Stem Cell of user-friendly venues: I Breaking Through the Age Barrier: Getting the Our advocacy efforts strengthened in March during Niche. Hematopoietic stem cells are the cells from Best Cancer Treatment, is a series of chapter-based I Call (800) 955-4572 or email the annual Mission Day in Washington, D.C. which all normal red and white blood cells derive, and educational workshops launched this year. More than ([email protected]) an information More than 250 Society supporters lobbied legislators adult stem cell transplantation is an important therapy half of all cancers occur in people older than 65, and specialist at our Information Resource Center to increase funding for various medical programs for individuals with advanced leukemia, lymphoma or important to cancer patients. these patients may need special attention when it I myeloma. Unfortunately, transplant success depends Visit our Web site at www.LLS.org 2 comes to cancer treatment. The program helps deter 005 | in part on the number of stem cells that can be Their efforts paid off. Despite significant federal budget the outdated notion that people in this age group I Learn the latest about any of the blood cancers recovered from donors, and blood stem cells are rare. cuts, the Society was able to secure an additional $5

are “too old” to benefit from therapies that are through our online education workshops and AN Dr. Scadden has discovered a drug, parathyroid million for blood cancer research at the U.S. Department standard for younger segments of the population. teleconferences, archived on our Web site of Defense, and an additional $5 million for blood N

hormone (PTH), that might increase pre-transplant U

The workshops familiarize older blood cancer patients AL I Visit or contact any of our 66 chapters in the cancer education provided by the Centers for Disease and their caregivers with information on treatments United States and Canada, providing information Control and Prevention. R EPOR and support services at the community level T

1011 2005 | ANNUAL REPORT donor development Society’s dynamic research programsThe depend Fiscal on the contributions of generous donors. development was no exception. Donor year 2005 million — revenue increased to more than $25 gifts The percent increase in a single year. a 38 initiatives contributed to funding such Society research Translational as the Specialized Center of Research, Research Program grants, and Career Development patient as well as chapter and Home Office-based service programs. . Soccer Kicks for SM , Pasta for Patients and for Patients , Pasta ® Programs offer children hands-on SM , the newest School & Youth addition, geared addition, , the newest School & Youth SM team in training (TNT), the world’s largest endurance In Training Team sports training program, enjoyed its best year ever. purple-clad TNT runners, walkers, More than 35,000 participatedcyclists and triathletes in over 60 events raising nearly $98 million around the country, Society’s mission. A milestone to help advance the when 9,000 runners and was reached last October A Marathon Nike 26.2, million at The walkers raised $10 & Lymphoma Leukemia to Benefit The for Women renamed the Nike inaugural event, since The Society. Marathon, achieved two importantWomen’s “firsts”: the and the first first marathon dedicated to a single charity marathon in which all participantsthe opportunity had for cancer. to raise funds to help the Society find cures school and youth School & Youth toward young soccer players, continued its national toward young soccer players, continued expansion. HOP for Leukemia & Lymphoma Cancer experiences that cultivate caring, respect and the value experiences that cultivate caring, respect funds of helping others while raising much-needed percent of all 18 to help advance our mission. In 2005, schools nationwide (kindergarten through grade) 12th — the most ever — signed up to participate in School for Patients Pennies & Youth’s light the night continued its impressive growth Night Walk Light The charity walk. Launched in 1998, as a leading national held every fall in communities Night is Light The and Canada, celebrating across the United States In fiscal lives touched by cancer. and commemorating people participated — the 175,000 nearly year 2005, million to help advance the $25 most ever — raising over the percent increase Society’s mission — a 36 welcomed Ray Evernham, Society also The previous year. NASCAR great friend, as national and long-time Society popularity and Night chairperson. Evernham’s Light The prestige in the sport Night to The helped promote Light the huge NASCAR audience.

highlights 2005 fundraising 2005 1213

research grants*

Specialized Center of Research 1 Susan Biggins, PhD • 2006 Wei Gu, PhD • 2002 15 Hiten Madhani, MD, PhD • 2006 Fred Hutchinson Cancer Columbia University University of California, San Francisco 2 Jerry Adams, PhD • 2002 Research Center Walter & Eliza Hall Institute Xi He, PhD • 2006 Andreas Matouschek, PhD • 2003 of Medical Research Katherine Borden, PhD • 2001 Children’s Hospital Boston Northwestern University University of Montreal, Canada Irwin D. Bernstein, MD • 2003 3 Theodore Jardetzky, PhD • 2002 16 Danesh Moazed, PhD • 2004 Fred Hutchinson Cancer James Bowie, PhD • 2002 Northwestern University Harvard Medical School Research Center University of California, Los Angeles Jin Jiang, PhD • 2004 George Mosialos, PhD • 2005 John Bushweller, PhD • 2005 4 Randy Brutkiewicz, PhD • 2004 University of Texas Biomedical Sciences Research Center University of Virginia Indiana University School of Medicine Dong-Yan Jin, MD, PhD • 2002 Matthew O’Connell, PhD • 2001 John C. Byrd, MD • 2006 5 Anthony Capobianco, PhD • 2002 University of Hong Kong Mount Sinai School of Medicine The Ohio State University Wistar Institute Craig Jordan, PhD • 2004 David Pellman, MD • 2001 Selina Chen-Kiang, PhD • 2001 J. Don Chen, PhD • 2001 University of Rochester Dana-Farber Cancer Institute Weill Medical College University of Medicine and Dentistry of Cornell University of New Jersey Jae Jung, PhD • 2001 Christoph Plass, PhD • 2003 New England Regional Primate The Ohio State University Riccardo Dalla-Favera, MD • 2004 6 Zhijian Chen, PhD • 2003 12 Research Center Columbia University University of Texas Ishwar Radhakrishnan, PhD • 2005 Scott Keeney, PhD • 2006 Northwestern University Brian J. Druker, MD • 2006 7 Genhong Cheng, PhD • 2001 Memorial Sloan-Kettering Cancer Center Howard Hughes Medical Institute University of California, Los Angeles Linda Resar, MD • 2006 Oregon Health & Science University Michelle Kelliher, PhD • 2004 17 Johns Hopkins University Cancer Institute Karlene Cimprich, PhD • 2005 University of Massachusetts School of Medicine Stanford University School of Medicine Medical School James Griffin, MD • 2006 8 Theodora Ross, MD, PhD • 2006 Dana-Farber Cancer Institute Pamela Correll, PhD • 2003 William Kerr, PhD • 2003 18 University of Michigan Medical Center Pennsylvania State University University of South Florida Helen Heslop, MD • 2004 Guy Sauvageau, MD, PhD • 2003 Baylor College of Medicine Patricia Cortes, PhD • 2002 Nigel Killeen, PhD • 2001 University of Montreal, Canada Mount Sinai School of Medicine University of California, San Francisco Carl June, MD • 2002 9 Stephen Schoenberger, PhD • 2006 University of Pennsylvania Chris Counter, PhD • 2003 Scott Kogan, MD • 2005 19 La Jolla Institute for Allergy Duke University Medical Center University of California, San Francisco and Immunology Thomas J. Kipps, MD, PhD • 2006 University of California, San Diego John Crispino, PhD • 2006 Anthony Koleske, PhD • 2003 Ralph Scully, MD, PhD • 2006 University of Chicago Yale University Beth Israel Deaconess Medical Center Ronald Levy, MD • 2006 Stanford University School of Medicine Blossom Damania, PhD • 2006 Kerry Kornfeld, MD, PhD • 2002 20 David Seldin, MD, PhD • 2001 University of North Carolina Washington University Boston Medical Center Scott Lowe, PhD • 2004 10 at Chapel Hill Cold Spring Harbor Laboratory Stephen Kron, MD, PhD • 2003 21 David Sharp, PhD • 2005 James DeGregori, PhD • 2001 University of Chicago Albert Einstein College of Medicine Tak Mak, PhD • 2005 University of Colorado Advanced Medical Discovery Institute Health Sciences Center Matthew Krummel, PhD • 2006 Ali Shilatifard, PhD • 2002 23 University of Toronto, Canada University of California, San Francisco Saint Louis University Wei Du, PhD • 2004 School of Medicine Stephen Nimer, MD • 2002 11 University of Chicago Gustavo Leone, PhD • 2005 Memorial Sloan-Kettering Cancer Center The Ohio State University Ramesh Shivdasani, MD, Michael Eck, MD, PhD • 2003 PhD • 2001 Cheryl L. Willman, MD • 2006 Dana-Farber Cancer Institute Daniel Lew, PhD • 2001 Dana-Farber Cancer Institute University of New Mexico Duke University Medical Center Health Sciences Center Christine Eischen, PhD • 2005 Peter Sicinski, MD, PhD • 2006 University of Nebraska Medical Center Xin Lin, PhD • 2005 Dana-Farber Cancer Institute University of Texas Career Development Program: Xin-Hua Feng, PhD • 2004 Tomasz Skorski, MD, PhD • 2001 Scholars Baylor College of Medicine Hsiou-Chi Liou, PhD • 2001 Temple University Weill Medical College Peter Adams, PhD • 2004 Margaret Goodell, PhD • 2002 13 of Cornell University Reshma Taneja, PhD • 2003 Fox Chase Cancer Center Baylor College of Medicine Mount Sinai School of Medicine Fenyong Liu, PhD • 2002 22 David Allman, PhD • 2005 Jonathan Graff, MD, PhD • 2002 14 University of California, Berkeley William Tansey, PhD • 2002 University of Pennsylvania University of Texas Cold Spring Harbor Laboratory Clifford Lowell, MD, PhD • 2002 Francisco Asturias, PhD • 2002 H. Leighton Grimes, PhD • 2006 University of California, San Francisco Scripps Research Institute University of Louisville

* The year displayed after each grant represents 4 Dr. John Bushweller is funded in part by and Karen Finkel, Paul and Susan Friedman, 9 Dr. Carl June is funded in part by Lisa Bee. the first year of grant activity. the Peter Berg Memorial Research Fund. Jonathan and Jeannie Lavine and Family, 10 Dr. Scott Lowe is funded in part by the Links Tom Marano, Jeffrey and Katina Mayer, The 5 Dr. John Byrd is funded in part by Douglas for Life-Cure Leukemia Foundation, the Alverin Edward L. Milstein Foundation, Michael and 1 The Specialized Center of Research Program and Phyllis Smith, Elaine S. Smith, Michael M. Cornell Foundation and Valerie Aspinwall Elin Nierenberg and Family, Daniel and Carol is supported in part by The John and Frances Thomas and Joseph D. Johnson. & The Reichman Memorial/Altschul Foundation Spina and Joseph S. and Diane H. Steinberg. Beck Family Foundation and General Motors. and Kathy and Chip McNamara. 6 Dr. Riccardo Dalla-Favera is funded in part 7 Dr. Brian Druker is funded in part by the 2 Dr. Jerry Adams is funded in part by Eli Lilly from David and Diann Sant, Cathy and Scott 11 Dr. Stephen Nimer is funded in part by The Bertelsen Family and the Kathy Soloff CML and Company. Zeilinger Philanthropic Fund, Lesley Goldwasser John and Shirley Davies Foundation. Research Fund 2005. and Jonathan Plutzik, Ruth and Carl Shapiro 3 Dr. Irwin Bernstein is funded by an 12 Dr. Zhijian Chen is funded by the St. Valentine’s Family Foundation, Deborah and Jeff Briggs, 8 Dr. James Griffin is funded in part by the anonymous donor. Day Luncheon and Style Show. Tracy and Frank Collins, James F. Egan, James Virginia Sheldon Jerome Foundation. 14

Michael Teitell, MD, PhD • 2004 24 John C. Byrd, MD • 2002 25 Klara Briknarova, PhD • 2005 Julie Gates, PhD • 2006 University of California, Los Angeles The Ohio State University Burnham Institute University of North Carolina at Chapel Hill Dimitris Thanos, PhD • 2001 Martin Carroll, MD • 2004 Katja Bruckner, PhD • 2004 Biomedical Sciences Research Center University of Pennsylvania Harvard Medical School Xinsheng Gao, PhD • 2004 University of Texas Michael Thirman, MD • 2003 Kenneth Cooke, MD • 2006 Xin Chen, PhD • 2006 University of Chicago University of Michigan Stanford University Marc Gavin, PhD • 2004 University of Washington David Toczyski, PhD • 2004 Jorge Cortes, MD • 2001 Aiyang Cheng, PhD • 2004 University of California, San Francisco University of Texas Yale University School of Medicine Felicia Goodrum Flood, PhD • 2004 Princeton University Toshio Tsukiyama, PhD, DVM • 2003 Glenn Dranoff, MD • 2001 Rafal Ciosk, PhD • 2006 Fred Hutchinson Cancer Dana-Farber Cancer Institute Fred Hutchinson Cancer Vanesa Gottifredi, PhD • 2003 Research Center Research Center Fundacion Instituto Leloir Ephraim Fuchs, MD • 2004 Jessica Tyler, PhD • 2004 Johns Hopkins University Hilary Coller, PhD • 2003 27 Karen Haas, PhD • 2005 University of Colorado School of Medicine Princeton University Duke University Medical Center Health Sciences Center Omer Koc, MD • 2002 Sean Conner, PhD • 2005 Tomoko Hamma, PhD • 2006 Katharine Ullman, PhD • 2006 Case Western Reserve University University of Minnesota, Twin Cities Fred Hutchinson Cancer University of Utah Research Center Zihai Li, MD, PhD • 2006 Xu-Ming Dai, MD, PhD • 2003 David Van Vactor, PhD • 2001 University of Connecticut Albert Einstein College of Medicine Joo Seok Han, PhD • 2006 Harvard Medical School Ludwig Institute for Cancer Research Owen O’Connor, MD, PhD • 2003 Nika Danial, PhD • 2004 Jose Villadangos, PhD • 2005 Memorial Sloan-Kettering Cancer Center Dana-Farber Cancer Institute Azizul Haque, PhD • 2004 Walter & Eliza Hall Institute Medical University of South Carolina of Medical Research Robert Orlowski, MD, PhD • 2006 Roberto De Guzman, PhD • 2003 University of North Carolina Scripps Research Institute Kieran Harvey, PhD • 2006 Claire Walczak, PhD • 2002 at Chapel Hill University of California, Berkeley Indiana University Medical Center Zhong Deng, PhD • 2006 Aaron Rapoport, MD • 2002 Wistar Institute Beate Heissig, MD, PhD • 2004 Xiaolu Yang, PhD • 2005 University of Maryland Juntendo University University of Pennsylvania Laxminarayana Devireddy, Jeffrey Taub, MD • 2003 PhD • 2003 28 Ke Hu, PhD • 2006 Tso-Pang Yao, PhD • 2004 Wayne State University University of Massachusetts Scripps Research Institute Duke University Medical Center Children’s Hospital of Michigan Medical School Tara Huber, PhD • 2006 Kyoko Yokomori, PhD, DVM • 2001 Christopher Walsh, MD, PhD • 2001 Joaquin Espinosa, PhD • 2004 Mount Sinai School of Medicine University of California, Irvine Mount Sinai School of Medicine University of Colorado at Boulder Matthias Hundt, MD • 2006 Hongtao Yu, PhD • 2004 Joseph Wiemels, PhD • 2004 26 John Farrar, PhD • 2002 La Jolla Institute for Allergy University of Texas University of California, San Francisco University of Texas and Immunology

Weiguo Zhang, PhD • 2005 Hui Feng, PhD • 2006 Lena Hwang, PhD • 2003 Duke University Medical Center Career Development Program: Dana-Farber Cancer Institute University of California, San Francisco Special Fellows Pengbo Zhou, PhD • 2006 Josephine Ferreon, PhD • 2006 Miho Iijima, PhD • 2005 Manzoor Ahmad, PhD • 2003 Scripps Research Institute Johns Hopkins University Weill Medical College National Institute of Allergy School of Medicine of Cornell University & Infectious Disease Harold Fisk, PhD • 2003 The Ohio State University Irena Ivanovska, PhD • 2005 Laurie Ailles, PhD • 2004 Career Development Program: Whitehead Institute for Biomedical Stanford University Scholars in Clinical Research Elsa Flores, PhD • 2004 29 Research University of Texas Maurizio Bendandi, MD, PhD • 2002 K. Mark Ansel, PhD • 2006 Julie Jameson, PhD • 2004 University of Navarra CBR Institute of Biomedical Casey Fox, PhD • 2005 Scripps Research Institute Research, Inc. University of Pennsylvania Ravi Bhatia, MD • 2003 Edith Janssen, PhD • 2005 City of Hope National Medical Center Toshiyuki Araki, PhD • 2006 Maxim Frolov, PhD • 2003 La Jolla Institute for Allergy Beth Israel Deaconess Medical Center University of Illinois at Chicago Smita Bhatia, MD • 2002 and Immunology City of Hope National Medical Center Kamel Benlagha, PhD • 2003 Pierre-Henri Gaillard, PhD • 2003 Sue Jaspersen, PhD • 2005 University of Chicago Scripps Research Institute Robert Brodsky, MD • 2001 Stowers Institute for Medical Research Johns Hopkins Oncology Center Ittai Ben-Porath, PhD • 2005

Janusz Kabarowski, PhD • 2003 2 Whitehead Institute for Biomedical University of Alabama at Birmingham 005 Research | AN 13 Dr. Margaret Goodell, a Stephen Birnbaum 17 Dr. Michelle Kelliher is funded by the 22 Dr. Fenyong Liu is funded in part by the 27 Dr. Hillary Coller is funded by the Quest For

Scholar, is funded by The Stephen Birnbaum Gold-Diggers, Inc. Wayne and Gladys Valley Foundation. the Cure Research Fund. N Foundation. 18 Dr. William Kerr is funded by The Newman 23 Dr. Ali Shilatifard is funded by the Ed Heitz 28 Dr. Laxminarayana Devireddy is funded in U

14 Dr. Jonathan Graff is funded by the St. Valentine’s Foundation. Memorial Research Fund. part by the Remillard Family Foundation, Inc. AL Day Luncheon and Style Show. 19 Dr. Scott Kogan is funded in part by The 24 Dr. Michael Teitell is funded by Parents 29 Dr. Elsa Flores is funded by the Hildegarde 15 Dr. Wei Gu is funded in part by the Wipe Out San Francisco Foundation. Against Leukemia. D. Becher Foundation. R Leukemia Forever Foundation, Inc. EPOR 20 Dr. Kerry Kornfeld is funded by the Ed Heitz 25 Dr. John Byrd is funded by the Bruce Bocina 16 Dr. Theodore Jardetzky is funded in part Memorial Research Fund. Building Corp. by the Helen Brach Foundation. 21 Dr. Stephen Kron is funded in part by 26 Dr. Joseph Wiemels is funded by Team Friends T Vito Ippolito and Kathryn O’Connor-Ippolito. of Allie-Honoring Sam Eisenberg and Allie Scott. 15

research grants continued

Cheng-Fu Kao, PhD • 2006 Constantine Mitsiades, MD, Jill Schweitzer, PhD • 2004 Research Center University of New Mexico PhD • 2004 University of Notre Dame Dana-Farber Cancer Institute Hans-Guido Wendel, MD • 2006 Chang Kim, PhD • 2003 Clare Scott, MD, PhD • 2004 Cold Spring Harbor Laboratory Purdue University Massimo Morra, MD • 200 Walter & Eliza Hall Institute of Medical Beth Israel Deaconess Medical Center Research Geng Wu, PhD • 2006 Alexei Kisselev, PhD • 2002 Children’s Hospital Boston Dartmouth College Raul Mostoslavsky, MD, PhD • 2005 Neil Shah, MD, PhD • 2005 Harvard Medical School University of California, Los Angeles Ting-Ting Wu, PhD • 2002 Paul Knoepfler, PhD • 2003 University of California, Los Angeles Fred Hutchinson Cancer Leon Murphy, PhD • 2004 Jeffrey Singer, PhD • 2002 Research Center Harvard Medical School Brown University Zhaohui Wu, PhD • 2006 University of Wisconsin, Madison Eric Lai, PhD • 2005 Mikhail Nikiforov, PhD • 2003 Chi Wai So, PhD • 2003 Memorial Sloan-Kettering Cancer Center University of Michigan The Institute of Cancer Research Ping Xie, PhD • 2003 University of Iowa Emma Langley, PhD • 2006 Ryoma Ohi, PhD • 2005 Yongcheng Song, PhD • 2006 Scripps Research Institute Harvard Medical School University of Illinois Tomoki Yokochi, PhD • 2006 at Champaign-Urbana Upstate Medical University Yvette Latchman, PhD • 2003 Joseph Opferman, PhD • 2005 Puget Sound Blood Center Dana-Farber Cancer Institute Eric Spierings, PhD • 2005 Akihiko Yokoyama, PhD • 2006 Leiden University Medical Center Stanford University School of Medicine Isabelle Le Blanc, PhD • 2005 Sean O’Rourke, PhD • 2006 University of California, Berkeley University of Oregon Walter Steiner, PhD • 2005 Jianbo Yue, PhD • 2006 Niagara University Stanford University School of Medicine Ziqiang Li, PhD • 2006 Amir Oryan (Orian), MD, Albert Einstein College of Medicine PhD • 2005 31 Angela Stoddart, PhD • 2005 Jinsong Zhang, PhD • 2004 Technion, Israel Institute of Technology University of Chicago University of Cincinnati YuYao Liang, PhD • 2006 University of Texas Laura Pasqualucci, MD • 2003 Valery Sudakin, DSC • 2003 Wei-Xing Zong, PhD • 2004 Columbia University Fox Chase Cancer Center University of Pennsylvania Bin Liu, PhD • 2003 University of California, Los Angeles Kathrin Plath, PhD • 2005 Vinay Tergaonkar, PhD • 2005 Career Development Program: Whitehead Institute for Biomedical Salk Institute for Biological Studies Fellows Jidong Liu, PhD • 2006 Research Cold Spring Harbor Laboratory Scott Tibbetts, PhD • 2004 David Aiello, PhD • 2005 Supriya Prasanth, PhD • 2006 Louisana State University University of Massachusetts • Matthew Lorincz, PhD 2003 Cold Spring Harbor Laboratory Medical School Fred Hutchinson Cancer Benjamin Turk, PhD • 2003 Research Center Jian Qu, PhD • 2005 Yale University School of Medicine Dikran Aivazian, PhD • 2003 32 University of California, San Francisco Stanford University School of Medicine Hinh Ly, PhD • 2004 Takehiko Usui, PhD • 2005 Emory University Yosef Refaeli, PhD • 2003 Memorial Sloan-Kettering Cancer Center Jennifer Antonchuk, PhD • 2004 National Jewish Medical University Hospital of Lund Sami Malek, MD • 2004 30 and Research Center Fred van Leeuwen, PhD • 2004 University of Michigan Medical School Netherlands Cancer Institute Toshiyuki Araki, PhD • 2003 Inez Rogatsky, PhD • 2003 Beth Israel Deaconess Medical Center Brendan Manning, PhD • 2005 Hospital for Special Surgery Gelin Wang, PhD • 2004 Harvard School of Public Health University of Texas Bryan Barnhart, PhD • 2006 Joan Roig Amoros, PhD • 2003 University of Pennsylvania Yinghui Mao, PhD • 2005 Parc Cientific de Barcelona Jing Wang, MD, PhD • 2006 Columbia University CBR Institute of Biomedical Peggy Baudouin-Cornu, PhD • 2004 Akihide Ryo, MD, PhD • 2003 Research, Inc. Mount Sinai School of Medicine Alberto Martin, PhD • 2004 Yokohama City University University of Toronto, Canada Yanchang Wang, PhD • 2002 Marie Bleakley, MD • 2006 Hyung Ryoo, PhD • 2006 Florida State University Fred Hutchinson Cancer • Bernhard Mayr, MD 2003 New York University Research Center Universitat Erlangen-Nuernberg School of Medicine Wenyi Wei, PhD • 2006 Dana-Farber Cancer Institute Douglas Braaten, PhD • 2003 • Brooke McCartney, PhD 2002 Shireen Saleque, PhD • 2004 Washington University Carnegie Mellon University Children’s Hospital Boston Orion Weiner, PhD • 2005 University of California, San Francisco Benjamin Braun, MD, PhD • 2004 • Thomas Mercher, PhD 2006 Adrian Salic, PhD • 2006 University of California, San Francisco Brigham and Women’s Hospital Harvard Medical School Amy Weinmann, PhD • 2004 University of Washington Christine Brown, PhD • 2001 • Jung-Hyun Min, PhD 2005 Tomoyuki Sawado, PhD • 2005 City of Hope National Medical Center Memorial Sloan-Kettering Cancer Center Fred Hutchinson Cancer Markus Welcker, PhD • 2006 Research Center Fred Hutchinson Cancer

30 Dr. Sami Malek is funded by The Hearst 31 Dr. Amir Orian is funded by the Pamela 32 Dr. Dikran Aivazian is funded in part by Foundation, Inc. B. Katten Memorial Leukemia Research Friends of Sue Rinsky. Foundation.

16

Deirdre Buckley, PhD • 2004 33 Eun-Jin Hong, PhD • 2006 Vanessa Marsden, PhD • 2005 Stefanie Sarantopoulos, MD, Cold Spring Harbor Laboratory Harvard Medical School National Jewish Medical PhD • 2006 and Research Center Dana-Farber Cancer Institute Kurt Cannon, PhD • 2002 Daniel Hostetter, PhD • 2006 Harvard Medical School University of California, San Francisco Carla Martins, PhD • 2006 Joseph Scandura, MD, PhD • 2003 35 University of California, San Francisco Memorial Sloan-Kettering Cancer Center Iris Chan, MD, PhD • 2004 Kristen Hurov, PhD • 2004 Brigham and Women’s Hospital Dana-Farber Cancer Institute Sebastiaan Meijsing, PhD • 2005 David Schwartz, PhD • 2003 University of California, San Francisco Yale University Danica Chen, PhD • 2006 Jonathan Irish, PhD • 2006 Massachusetts Institute of Technology Stanford University Stavroula Mili, PhD • 2006 Gary Shapiro, PhD • 2005 Yale University School of Medicine University of California, San Diego Jihua Chen, MD, PhD • 2006 Brenda Irvin, PhD • 2003 Dana-Farber Cancer Institute Vanderbilt University Shinichi Mizuno, MD, PhD • 2004 Eric Shiozaki, PhD • 2006 Dana-Farber Cancer Institute University of California, Los Angeles Jing Chen, PhD • 2005 Kristen Johnson, PhD • 2006 Emory University University of Chicago Alexandre Morozov, PhD • 2006 Jonathan Snow, PhD • 2006 Rockefeller University Children’s Hospital Boston Dipanjan Chowdhury, PhD • 2005 Anna Keating, MD • 2004 CBR Institute of Biomedical Memorial Sloan-Kettering Cancer Center Valerie Notenboom, PhD • 2002 Holger Sondermann, PhD • 2003 Research, Inc. Netherlands Cancer Institute University of California, Berkeley Karen Keeshan, PhD • 2005 Kent Christopherson, PhD • 2004 University of Pennsylvania Xuewen Pan, PhD • 2004 Erinn Soucie, PhD • 2006 University of Texas Johns Hopkins University IRIC – Institut de Recherche en You-Me Kim, PhD • 2004 School of Medicine Immunovirologie et en ancerologie Warren D’Souza, PhD • 2006 Harvard Medical School University of California, San Diego Sebastien Pfeffer, PhD • 2005 34 Jason Tanny, PhD • 2006 Sridevi Khambhampaty, PhD • 2006 Rockefeller University Rockefeller University Zhong Deng, PhD • 2003 Stanford University School of Medicine Wistar Institute Lisa Postow, PhD • 2006 Vera Tarakanova, PhD • 2006 Marc Kvansakul, PhD • 2006 Rockefeller University Washington University in St. Louis Tracy Diamond, PhD • 2006 Walter & Eliza Hall Institute School of Medicine University of Pennsylvania of Medical Research Natalie Prigozhina, PhD • 2003 Scripps Research Institute Ewan Taylor, PhD • 2006 Li-Lin Du, PhD • 2003 Erica Larschan, PhD • 2005 Scripps Research Institute Scripps Research Institute Brigham and Women’s Hospital Martin Prlic, PhD • 2006 University of Washington Jorge Torres, PhD • 2006 Pinghui Feng, PhD • 2004 Dong Lee, PhD • 2006 Stanford University School of Medicine New England Regional Primate Salk Institute for Biological Studies Philippe Prochasson, PhD • 2004 Research Center Stowers Institute for Medical Research Su-Yi Tseng, PhD • 2004 Mathew Lensch, PhD • 2003 New York University Sylvia Fischer, PhD • 2005 Children’s Hospital Boston Ling Qi, PhD • 2003 School of Medicine Massachusetts General Hospital Salk Institute for Biological Studies Xiaoling Li, PhD • 2005 Lidia Vasilieva, PhD • 2005 Timothy Fisher, PhD • 2004 Massachusetts Institute of Technology Bin Qian, PhD • 2006 Harvard Medical School Princeton University University of Washington Zhe Li, PhD • 2005 Li Wang, PhD • 2004 James Forrest, PhD • 2005 Children’s Hospital Boston Priyamvada Rai, PhD • 2006 Dartmouth College Emory University Whitehead Institute for Biomedical Xiaozhen Liang, PhD • 2006 Research Ying-Jie Wang, PhD • 2004 Josefina Garcia, PhD • 2006 Harvard Medical School University of Texas Weill Medical College John Randell, PhD • 2004 of Cornell University Chinten Lim, PhD • 2005 Massachusetts Institute of Technology David Weinstock, MD • 2005 University of California, San Diego Memorial Sloan-Kettering Cancer Center Tania Gourley, PhD • 2004 Christopher Raymond, PhD • 2003 Emory University Stephen Lin, PhD • 2005 Fred Hutchinson Cancer Richard Willis, PhD • 2004 Dana-Farber Cancer Institute Research Center National Jewish Medical Yuli Guo, PhD • 2003 and Research Center Dana-Farber Cancer Institute Edward Luk, PhD • 2006 Lily Remsing Rix, PhD • 2005 National Institutes of Health Center for Molecular Medicine Jasmine Wong, PhD • 2006 Jacob Harrison, PhD • 2005 University of California, San Francisco Brandeis University Julian Lum, PhD • 2005 Stefan Riedl, PhD • 2005 University of Pennsylvania Burnham Institute Niels-Bjarne Woods, PhD • 2005 John Hines, PhD • 2003 Salk Institute for Biological Studies Yale University Eugene Makeyev, PhD • 2005 Adam Rosendorff, MD • 2003 Harvard University Brigham and Women’s Hospital Jingsong Xu, PhD • 2003 • Amy Holdorf, PhD 2004 University of California, San Francisco 2 Mount Sinai School of Medicine 005 | AN 33 Dr. Deidre Buckley is funded by Mr. and 34 Dr. Sebastien Pfeffer is funded by the Lehman 35 Dr. Joseph Scandura is funded by Michael

Mrs. Anthony Campbell and Mr. and Mrs. Brothers Foundation. Copley and Leslie Elliot Krause, Esq., in N Matthew Campbell. conjunction with Partners in Research. U AL R EPOR T

17 research grants continued

Zheng Xu, PhD • 2005 Pamela Becker, MD, PhD • 2006 Robert Collins, MD • 2004 41 Daniel Fernandes, PhD, DSC • 2006 Beth Israel Deaconess Medical Center University of Washington University of Texas Medical University of South Carolina

Tingting Yao, PhD • 2005 Antonio Bedalov, MD, PhD • 2006 Steven Collins, MD • 2004 42 Adele Fielding, PhD • 2003 Stowers Institute for Medical Research Fred Hutchinson Cancer Fred Hutchinson Cancer Mayo Clinic and Foundation Research Center Research Center Ping Yuan, PhD • 2006 Barry Finette, MD, PhD • 2003 Princeton University Steven Bernstein, MD • 2004 Kenneth Cooke, MD • 2004 University of Vermont University of Rochester University of Michigan Shan Zha, MD, PhD • 2005 Comprehensive Cancer Center Christopher Flowers, MD • 2006 Harvard School of Medicine, Steven Bernstein, MD • 2006 Emory University Children’s Hospital Boston University of Rochester Laurence Cooper, MD, PhD • 2003 City of Hope National Medical Center Francine Foss, MD • 2003 Jing Zhang, PhD • 2004 Ravi Bhatia, MD • 2003 Tuffs University Whitehead Institute for Biomedical City of Hope National Medical Center Laurence Cooper, MD, PhD • 2006 43 New England Medical Center Research City of Hope National Medical Center Smita Bhatia, MD • 2002 Arthur Frankel, MD • 2005 Xiaowu Zhang, PhD • 2003 City of Hope National Medical Center Richard D’Andrea, PhD • 2004 Scott and White Memorial Whitehead Institute for Biomedical Child Health Research Institute Hospital and Clinic Research Bruce Blazar, MD • 2004 University of Minnesota, Twin Cities Bryant Darnay, PhD • 2002 Ephraim Fuchs, MD • 2002 Song Zhao, MD, PhD • 2005 University of Texas Johns Hopkins University Memorial Sloan-Kettering Cancer Center Carl Borrebaeck, DSC • 2006 School of Medicine Lund University Albert Deisseroth, MD, PhD • 2004 Rui Zhou, PhD • 2005 Sidney Kimmel Cancer Center Varsha Gandhi, PhD • 2005 47 Harvard Medical School Roger Briesewitz, PhD • 2005 39 University of Texas The Ohio State University Joseph DiCarlo, MD • 2005 44 Daniel Zilberman, PhD • 2006 Stanford University Irene Ghobrial, MD • 2006 Fred Hutchinson Cancer John Bushweller, PhD • 2002 Dana-Farber Cancer Institute Research Center University of Virginia Clark Distelhorst, MD • 2006 Case Western Reserve University Spencer Gibson, PhD • 2005 Weiguo Zou, PhD • 2006 Janet Butel, PhD • 2003 University of Manitoba, Canada Scripps Research Institute Baylor College of Medicine Dirk Dittmer, PhD • 2006 University of North Carolina Spencer Gibson, PhD • 2002 John C. Byrd, MD • 2005 40 at Chapel Hill University of Manitoba, Canada Translational Research Program The Ohio State University • • Vahid Afshar-Kharghan, MD • 2003 36 Nicholas Donato, PhD 2002 D. Gary Gilliland, MD, PhD 2003 Michael Caligiuri, MD • 2006 University of Texas Howard Hughes Medical Institute Baylor College of Medicine The Ohio State University Brigham and Women’s Hospital Ming-Qing Du, MD, PhD • 2003 Ricardo Aguiar, MD, PhD • 2002 Harvard Medical School Martin Carroll, MD • 2004 University of Cambridge Dana-Farber Cancer Institute University of Pennsylvania D. Gary Gilliland, MD, PhD • 2006 Ming-Qing Du, MD, PhD • 2005 Denis Alexander, PhD • 2003 Howard Hughes Medical Institute Ethel Cesarman, MD, PhD • 2002 University of Cambridge Babraham Institute Brigham and Women’s Hospital Weill Medical College Harvard Medical School of Cornell University Dimitar Efremov, MD, PhD • 2006 Stephen Ansell, MD, PhD • 2004 37 International Centre for Genetic • Mayo Clinic and Foundation Jianlin Gong, MD 2004 Preet Chaudhary, MD, PhD • 2006 Engineering and Biotechnology Boston University University of Pittsburgh Scott Armstrong, MD, PhD • 2004 38 Elizabeth Eklund, MD • 2002 • Children’s Hospital Boston Steven Gore, MD 2005 Wei Chen, MD, PhD • 2005 Northwestern University Johns Hopkins University University of Minnesota, Twin Cities David Avigan, MD • 2002 School of Medicine School of Medicine Beth Israel Deaconess Medical Center Selina Chen-Kiang, PhD • 2006 Elizabeth Eklund, MD • 2006 Stephen Gottschalk, MD • 2004 Weill Medical College David Avigan, MD • 2005 Northwestern University Baylor College of Medicine of Cornell University Beth Israel Deaconess Medical Center School of Medicine Steven Grant, MD • 2003 Linzhao Cheng, PhD • 2002 • 45 Maria Baer, MD • 2003 Stephen Emerson, MD, PhD 2005 Virginia Commonwealth University Johns Hopkins University Roswell Park Cancer Institute University of Pennsylvania School of Medicine Steven Grant, MD • 2006 Deborah Banker, PhD • 2002 Carolyn Felix, MD • 2002 Virginia Commonwealth University Jason Chesney, MD, PhD • 2006 Fred Hutchinson Cancer The Children’s Hospital of Philadelphia University of Louisville • Research Center Ian Harmer, PhD 2003 Dean Felsher, MD, PhD • 2004 46 University of Cambridge Rachael Clark, MD, PhD • 2006 Dwayne Barber, PhD • 2005 Stanford University School of Medicine Brigham and Women’s Hospital Ontario Cancer Institute, Canada Charles Hemenway, MD, Robert Fenton, MD, PhD • 2004 PhD • 2005 48 Bayard Clarkson, MD • 2004 University of Maryland Tulane University School of Medicine Memorial Sloan-Kettering Cancer Center

36 Dr. Vahid Afshar-Kharghan is funded by the 39 Dr. Roger Briesewitz is funded in part by the 43 Dr. Laurence Cooper is funded by The Gail 47 Dr. Varsha Ghandi is funded by the Jim Jacobs MPD Foundation in partnership with Friends Friends of Jeff Sachs. Cohen Leukemia Fund. Leukemia Research Fund. of Essential Thrombocythemia, Inc. and The 40 Dr. John Byrd is funded by Stephen and 44 Dr. Joseph DiCarlo is funded in part by the 48 Dr. Charles Hemenway is funded in part by Leukemia & Lymphoma Society. Madeleine Anbinder and In memory Mario Lemieux Foundation. Anabel Wheeler, Bob Gadomski, Shahan 37 Dr. Stephen Ansell is funded in part by of Andrew C. Renz, M.D. and Camilla Soghikian. 45 Dr. Stephen Emerson, a Stephen Birnbaum Phyllis Rubinstein in honor of Lisa Mulman. 41 Dr. Robert Collins is funded by the St. Scholar, is funded by The Stephen Birnbaum 49 Dr. Craig Jordan is funded in part by the 38 Dr. Scott Armstrong is funded by the Connors Valentine’s Day Luncheon and Style Show. Foundation. Douglas Kroll Research Program. Family Charitable Fund, Jack and Eileen 42 Dr. Steven Collins is funded by the Quest 46 Dr. Dean Felsher is funded in part by the Connors, Willy’s Fund and the William Wesley For the Cure Research Fund. Valentine Foundation. Kelly Research Fund.

18

Craig Jordan, PhD • 2006 49 Hector Martinez-Valdez, MD, Dirk Reinhardt, MD • 2002 Michael Tomasson, MD • 2003 65 University of Rochester PhD • 2003 Universitätsklinikum Münster Washington University University of Texas Scott Kaufmann, MD, PhD • 2005 50 Alain Rook, MD • 2002 Max Topp, MD • 2004 Mayo Clinic and Foundation Kenneth Meehan, MD • 2006 University of Pennsylvania University of Wuerzburg Dartmouth-Hitchcock Medical Center Thomas Kipps, MD, PhD • 2004 Alain Rook, MD • 2005 Joseph Tuscano, MD • 2004 University of California, San Diego Ari Melnick, MD • 2006 University of Pennsylvania University of California, Davis Albert Einstein College of Medicine Krishna Komanduri, MD • 2006 Cliona Rooney, PhD • 2002 Marcel van den Brink, MD, University of Texas David Miklos, MD, PhD • 2006 Baylor College of Medicine PhD • 2006 Stanford University Memorial Sloan-Kettering Cancer Center Marina Konopleva, MD, PhD • 2002 Research Cancer Center Janet Rowley, MD • 2006 57 University of Texas University of Chicago Andrea Velardi, MD • 2002 66 Wilson Miller, MD, PhD • 2003 Università di Perugia Steven Kornblau, MD • 2003 Jewish General Hospital, Lady Davis Felipe Samaniego, MD • 2006 University of Texas Institute for Medical Research, Canada University of Texas Edmund Waller, MD, PhD • 2002 Emory University Steven Kornblau, MD • 2006 Mark Minden, MD, PhD • 2003 David Scadden, MD • 2005 58 University of Texas Ontario Cancer Institute, Canada Massachusetts General Hospital J. Brice Weinberg, MD • 2006 Duke University Medical Center Simon Lacey, PhD • 2002 Shakeel Modak, MD, PhD • 2004 53 Aaron Schimmer, MD, PhD • 2004 59 Beckman Research Institute Memorial Sloan-Kettering Cancer Center Princess Margaret Hospital, Canada David Williams, MD • 2006 Cincinnati Children’s Hospital Simon Lacey, PhD • 2005 Malcolm Moore, MD • 2006 Stephen Schuster, MD • 2002 Medical Center Beckman Research Institute Memorial Sloan-Kettering Cancer Center University of Pennsylvania Xiao-Feng Yang, MD, PhD • 2004 67 Jill Lacy, MD • 2004 Benjamin Neel, MD, PhD • 2004 Stephen Schuster, MD • 2006 Baylor College of Medicine Yale University School of Medicine Beth Israel Deaconess Medical Center University of Pennsylvania Qing Yi, MD, PhD • 2003 Uma Lakshmipathy, PhD • 2004 Susan Nilsson, PhD • 2004 Oliver Semmes, PhD • 2003 University of Texas University of Minnesota, Twin Cities Peter MacCallum Cancer Institute Eastern Virginia Medical School Muxiang Zhou, MD • 2005 Lawrence Lamb, PhD • 2003 Lawrence Panasci, MD • 2006 Judith Shizuru, MD, PhD • 2003 60 Emory University University of Alabama at Birmingham Lady Davis Institute for Medical Stanford University Research, Canada Charles Lee, PhD • 2005 Sherrill Slichter, MD • 2002 61 Brigham and Women’s Hospital Peter Parham, PhD • 2004 54 Puget Sound Blood Center Stanford University School of Medicine and Program Robert Lee, PhD • 2002 The Ohio State University Roger Pearse, MD, PhD • 2006 Florence Smadja, PhD • 2003 Weill Medical College of Cornell Institut Universitaire d’hématologie 51 Hyam Levitsky, MD • 2005 University Johns Hopkins University School Donald Small, MD, PhD • 2004 62 of Medicine Christoph Plass, PhD • 2005 55 Johns Hopkins University The Ohio State University Jane Liesveld, MD • 2004 52 Mitchell Smith, MD, PhD • 2003 63 University of Rochester Jonathan Pollack, MD, PhD • 2006 Fox Chase Cancer Center Stanford University Michael Lilly, MD • 2002 Lloyd Stoolman, MD • 2004 Loma Linda University Miles Prince, MD • 2005 University of Michigan Peter MacCallum Cancer Centre Bing Lim, MD, PhD • 2003 Alison Stopeck, MD • 2002 Beth Israel Deaconess Medical Center Miles Prince, MD • 2006 Arizona Cancer Center Peter MacCallum Cancer Centre Jose Lopez, MD • 2005 Moshe Talpaz, MD • 2004 Baylor College of Medicine Louise Purton, PhD • 2003 University of Texas Peter MacCallum Cancer Institute Lawrence Lum, MD, DSC • 2005 Ana Tari, PhD • 2006 Roger Williams Medical Center Shahin Rafii, MD • 2004 56 University of Texas Weill Medical College 64 Guitta Maki, PhD • 2003 of Cornell University Michael Thirman, MD • 2005 Rush University Medical Center University of Chicago S. Vincent Rajkumar, MD • 2003 Otoniel Martinez-Maza, PhD • 2003 Mayo Clinic and Foundation John Timmerman, MD • 2006 University of California, Los Angeles University of California, Los Angeles

Yosef Refaeli, PhD • 2006 2 National Jewish Medical 005 and Research Center | AN 50 Dr. Scott Kaufmann is funded by Clyde 55 Dr. Christoph Plass is funded by Stephen 60 Dr. Judith Shizuru is funded by an anonymous 65 Dr. Michael Tomasson is funded in part by the

McGregor and Joan Kowling McGregor. and Madeline Anbinder. donor. Links for Life-Cure Leukemia Foundation. N

51 Dr. Hyam Levitsky is partially funded 56 Dr. Shahin Rafii is funded by the Douglas 61 Dr. Sherrill Slichter is funded by the Quest 66 Dr. Andrea Velardi is funded by an anonymous U

by Milton Lichtman. Kroll Research Program. For the Cure Research Fund. donor. AL 52 Dr. Jane Liesveld is funded in part by the 57 Dr. Janet Rowley is funded by The Coleman 62 Dr. Donald Small is funded by the Douglas 67 Dr. Xiao-Feng Yang is funded by the MPD Douglas Kroll Research Program. Foundation. Kroll Research Program. Foundation in partnership with Friends R of Essential Thrombocythemia, Inc. and EPOR 53 Dr. Shakeel Modak is funded by an 58 Dr. David Scadden is funded by the F.M. 63 Dr. Mitchell Smith is funded by an anonymous The Leukemia & Lymphoma Society. anonymous donor. Kirby Foundation. donor. 54 Dr. Peter Parham is funded in part by 59 Dr. Aaron Schimmer is funded in part by 64 Dr. Michael Thirman is funded by The Coleman T Mrs. Dee Sanfilippo. John R. Jones, Jr. and In memory of Diane Foundation. Sierzega Ware. 19 medical and professional scientific advisors education subcommittee

Beverly S. Mitchell, MD • Chair * Kanti R. Rai, MD Irwin D. Bernstein, MD • Chair Joel Rappeport, MD Cancer Research Center Long Island Jewish Medical Center Fred Hutchinson Cancer Yale School of Medicine Stanford University Research Center Joel Rappeport, MD Margaret A. Shipp, MD Armand Keating, MD • Vice Chair Yale School of Medicine Selina Chen-Kiang, PhD Dana-Farber Cancer Institute Princess Margaret Hospital Weill Medical College Steven T. Rosen, M.D of Cornell University Guido J. Tricot, PhD Irwin D. Bernstein, MD Robert H. Lurie Comprehensive University of Arkansas Fred Hutchinson Cancer Cancer Center Brian J. Druker, MD for Medical Sciences Research Center Howard Hughes Medical Institute Naomi Rosenberg, PhD * Oregon Health & Science University David Bodine, PhD Tufts University School of Medicine Cancer Institute National Institutes of Health Margaret A. Shipp, MD Judith E. Karp, MD Selina Chen-Kiang, PhD Dana-Farber Cancer Institute The Bunting Blaustein Cancer Weill Medical College Research Building of Cornell University Guido J. Tricot, MD, PhD University of Arkansas Curt I. Civin, MD Michael W. Long, PhD for Medical Sciences Johns Hopkins Comprehensive Velcura Therapeutics, Inc. Cancer Center Cheryl L. Willman, MD Beverly S. Mitchell, MD Brian J. Druker, MD University of New Mexico Cancer Research Center Howard Hughes Medical Institute Health Sciences Center Stanford University Oregon Health & Science University Cancer Institute

Alan M. Gewirtz, MD * University of Pennsylvania School of Medicine

D. Gary Gilliland, MD, PhD Howard Hughes Medical Institute Brigham and Women’s Hospital Harvard Medical School

James Griffin, MD Dana-Farber Cancer Institute

Judith E. Karp, MD The Bunting Blaustein Cancer endowment Research Building funds Michael W. Long, PhD * Velcura Therapeutics, Inc. Charlotte Meyers Research Fund W. Stratford May, MD, PhD * University of Florida de Villiers Endowment Fund

Warren S. Pear, MD, PhD GlaxoSmithKline Foundation & GlaxoSmithKline, Inc. Research Fund Abramson Family Cancer Research Institute Jim Jacobs Leukemia Research Fund

Mary & Robert Bronstein Memorial Fund

The Rachel Kudish Fund

The Rae Endowment Fund

Reich Educational Fund

Thomas M. Ford Memorial Fund

The UFCW Endowment Fund

The Virginia Major Brooks Memorial Endowment Fund

Vrushali Ranadive Fellowship Fund

20 * Board of Directors donors

$1,000,000 and above Michael Thomas $10,000 — $49,999 Stanley E. Brown Family Foundation Anonymous The Virginia Sheldon Jerome Acco Brands, Inc. C. Scott Bruin Foundation United Food & Commercial Workers Breeden Adams Foundation Burlington Coat Factory (No. 165) International Union (UFCW) Alabama Power Foundation Burlington Coat Factory (No. 190) $50,000 — $99,999 David and Diann Sant Amgen Ms. Gwynnae Byrd Hildegarde D. Becher Foundation, Inc. Anonymous Florentine Camenisch Trust $500,000 — $999,999 The John and Frances Beck Family Ham Ansley Memorial Research Fund Campbell & Company Bristol-Myers Squibb Company Foundation APCI Rock the Night J. Terence and Sharon Carleton Mr. and Mrs. Carl H. Lindner, Jr. Berlex Lance Armstrong Foundation Wayne and Fran Carlisle Novartis The Bill Bernbach Foundation Mary J. Arnett Trust Glenn and Lynne Carlson Bost Custom Homes Mr. and Mrs. James Ashworth The Ronald Harlin Carr Foundation $100,000 — $499,999 Mr. and Mrs. Anthony Campbell Atlanta Thrashers Foundation The Castellini Foundation Anonymous – Maryland Mr. and Mrs. Matt Campbell The Sandra Atlas Bass & Edythe Cephalon Chapter Leader Chatham Development Corporation & Sol G. Atlas Fund, Inc. Challenging the Course of Cancer Stephen and Madeline Anbinder Chicago Cosmetologists Association Auburn Panhellenic Council Thomas Chapman Valerie Aspinwall & The Reichman Bank of America Memorial/Altschul Foundation Faro Foundation Children’s Charities Foundation Mrs. Angie Barrett The Bertelsen Family Foxwood Homes, Inc. David and Mary Christensen John and Eileen Barrett The Stephen Birnbaum Foundation Friends of Essential CIBC World Market Corp Miracle Thrombocythemia, Inc. Mr. Doug Baughman Day USA Account Celgene Corporation Genzyme Bears Care Fund, a Fund of Cinergy Centers for Disease Control The Robert R. McCormick & Prevention GlaxoSmithKline Bruce and Isobel Cleland Tribune Foundation The Coleman Foundation Lesley Goldwasser and Jonathan Gail Cohen Leukemia Fund Mr. and Mrs. Joseph and Judith Plutzik Community Health Charities Community Health Charities Becelia of Connecticut The Jeff Gordon Foundation of Arizona Lisa Bee Diamond Ball/Ed Heitz Memorial Pete Harman Community Health Charities BellSouth Research Fund The Hearst Foundation, Inc. of California Beloved Dawgs Dinner Mr. and Mrs. Simon C. Fireman The Hollander Foundation Community Health Charities Benjamin Moore Paints of Illinois General Motors Foundation IDEC Jay H. Bernstein Community Health Charities HCS Foundation Jim Jacobs Charitable Foundation of Kentucky Jack Berkowitz CMML Virginia Sheldon Jerome Pamela B. Katten Memorial Research Fund Community Health Charities Foundation Leukemia Research Foundation of Wisconsin Alice Ann Bien Foundation William Wesley Kelly The Krutz Foundation Jack Connors Research Fund Bioenvision The Mario Lemieux Foundation Connors Family Charitable Fund F.M. Kirby Foundation, Inc. Biogen Idec Mr. and Mrs. Carl H. Lindner III Convergys Corporation Douglas Kroll Research Program Alexandra Mayes Birnbaum The Madoff Family Michael and Elizabeth Copley Susan Lang Foundation Stephen and Mary Birch Foundation, Millennium Inc. Alverin M. Cornell Foundation Lehman Brothers Foundation MPD Foundation Murray Blackman Corporex Companies LLC Rush Limbaugh Aldo Parcesepe BlueCross/BlueShield Of Alabama CSX Corporation Mr. and Mrs. S. Craig Lindner Parents Against Leukemia Anna and David Blumenfeld Danford Foundation Links for Life – Cure Leukemia Potawatomi Bingo Casino Foundation Mr. and Mrs. Edward Blumenfeld David Dashiell Jacques and Marlene Rubin Clyde McGregor and Joan Kowling Bruce Bocina Building Corp. The John and Shirley Davies The Victor E. and Caroline E. Schutte Foundation McGregor Boeing Employees Community Fund Foundation – Trust E 2 Leona E. and Donald W. Davis 005 Kathy and Chip McNamara Boeing Houston Employees Kathy Soloff CML Research Fund The Newman Foundation Community Fund The Marc David Foundation Elaine S. Smith | Quality Food Centers Ted Bollin Mary Del Bene AN Joseph S. and Diane H. Steinberg Parents Against Leukemia Steve Boom France and Andre Desmarais N The Mel Stottlemyre Myeloma U Peter Berg Memorial Research Fund Helen Brach Foundation Donny Deutsch AL Foundation

Dee Sanfilippo In Memory of Emerson B. Bridges Frank DiPascali R

Wayne and Gladys Valley Foundation EPOR Carl and Ruth Shapiro Eli & Edythe L. Broad Foundation The Edgar Family Charitable Fund Windward Homes Family Foundation Edgar and Clarissa Bronfman John P. Eidel Wish Upon A Star Gala 2005 T Douglas and Phyllis Smith Balloons Alex Brown & Sons Charitable Mr. and Mrs. Dennis and Dana Foundation Eisenberg 21 donors continued

Employees Community Fund Imlay Foundation Lowndes, Drosdick, Doster, Preferred Flooring of Boeing St. Louis Independent Research Group Kantor & Reed, PA The Jim Quay Memorial Team Entergy Services, Inc Insured Benefit Plans, Inc. Larry Luke Rags For Riches Foundation Elizabeth Fago Intergraph James Mahlmeister Remillard Family Foundation Fairway Lincoln-Mercury Vito Ippolito and Kathryn Manzi Family Charitable Foundation In Memory of Andrew C. Renz, MD Falk Family Foundation O’Connor-Ippolito Tom Marano James Resnick Denni and Nicholas Ferrara Alan K. & Cledith M. Jennings Richard and Christina Marcinek Mariana Richards Foundation Fisher Chevrolet-Kia Dr. and Mrs. Stanley Marks Jim Riha Art and Gwen Flaming Jewish Federation of Greater Mr. and Mrs. Mark E. Mason Philadelphia Art and Sue Rinsky Susan Fobes Jeffrey and Katina Mayer JMB Hope Foundation Rodman Ford Sales, Inc. Friends In Memory of Todd Alan MBM Corporation Joseph D. Johnson Martha W. Rogers Trust Whitman Mr. and Mrs. Jack McDonald John R. Jones, Jr. William G. Rohrer Charitable Friends of Jeff Sachs The Laffey McHugh Foundation Foundation Friends of Ligonier Polo Mr. and Mrs. Ralph C. and Sally Jones Mellon Bank Ronald McDonald House Charities Friends of Sean to Benefit The Meyer Memorial Trust The Rosewood Corporation Leukemia & Lymphoma Society Kenneth and Karen Kaplan Mr. and Mrs. Don and Martha Miller Phyllis Rubinstein Friends of Sue Rinsky David Adam Katz Edward L. Milstein Foundation Paul & Joan Rubschlager Fry Steel Company Keating, Muething and Klekamp PLL The Sidney Milton & Leoma Simon Foundation Dorothy Fuqua Dr. Dean and Anne Kereiakes Foundation Thomas Ryan Brad Gadomski Mr. and Mrs. Jack J. Kessler, Esq. David J. Mitchell Laura Landro Salomon and Richard Mariellen Gallagher Salomon Digby Kirby The Moody Foundation Melissa Gay The San Francisco Foundation Kirshenbaum Bond & Partners Morgan Keegan & Co. GE Corporate Financial Services Annunziata Sanguinetti Foundation Klein Family Foundation Robert Morrissey Genentech BioOncology Sarver Charitable Trust Paul Konigsberg, Esq. Jim Morrison Genzyme Charles and Julie Scheper Konigsberg Wolf & Co. PC Morrison Homes Dan and Debbie Gill Daniel and Andrea Schreiber Rita and Gene Kelly Mike Munchak Jill Gimelli National City The Victor E. and Caroline E. Schutte Pam and Keith Kelly Foundation – 1959 The Gold-Diggers, Inc. The Netter Foundation, Inc. Mary Anne Kenny and Karen Powers Mr. and Mrs. Stephen A. Schwarzman Samuel Goldberg & Sons New England Patriots Foundation Foundation, Inc. KLA Tencor Foundation The Schwartz Family Foundation Kenneth Newton Steve Gottlieb Charles Koller, MD Edith M. Schweckendieck Trusts Joseph and Deborah Norberg GPCA Krafty Ladies of Walnut Woods Renee and Stanley Shapiro Leslie Elliot Krause, Esq. Northwestern Mutual Life Mark Grace Foundation Foundation, Inc. The Peter Jay Sharp Foundation The Jean & E. Floyd Kvamme The Paul B. Greetin and Option One Mortgage Corp. Frank Short Beryl S. Greetin Foundation, Inc. Foundation Oracle Corporate Giving Program Robert and Pamela Sibey Marliss Gruver Marie Lamfrom Charitable Foundation The Oregon Community Foundation Mace Siegel Mr. Roger Guillaume, Jr. Rob Larocque and Carol Clause Osprey Foundation In Memory of Diane Sierzega Ware Hakluyt & Company Limited Richard Lavanture Panebraska LLC, a franchisee Sigma Alpha Epsilon Fraternity, Health Care Reit University of Georgia LLB Golf Tournament of Panera LLC The Helis Foundation (O.E. Community Service Fund) The Hoyt & Viorica Pardee Simpson Thacher & Bartlett Hendin Family The Lebenfeld Foundation Foundation Shahan and Camilla Soghikian Michelle Henkel The Tony Leffingwell Foundation Park Place Dealerships Matthew Spitzer Dulé Hill Mr. and Mrs. George Lehman Partners Healthcare System State of New York Department Hills Development Penn Treaty Network America of Health on behalf of Senator Michael Lewin Carl Marcellino History Heritage & Hope Foundation People’s Bank Steven Lieblich State of New York Department Aaron and Susan Hollander Richard Perlman Mr. and Mrs. James and Jennifer of Taxation and Finance on behalf Larry Holste Lincoln William L. Peters of Senator Charles Fuschillo Mike Hoover Mr. and Mrs. Keith E. Lindner Phi Gamma Delta Garrett L. Stauffer, CPA Gene Hovanec Milton Litchman Philips Lighting St. Joseph’s/Candler Hudson United Bank Local 148 Operating Engineers Ed & H Pillsbury Foundation John Stein ILEX Oncology, Inc. Thomas J. Long Foundation Pittsburgh Paint & Glass Company Marcie and Avy Stein

22 Mr. and Mrs. Randall and Stuart Lovett Polsinelli Shalton Welte Suelthaus Dr. and Mrs. Paul and Kathy Stephanie Imhoff Steinberg

sponsor partnerships

Sterling Equities Sponsors are institutions or $10,000 – $49,999 Brown Automotive Group individuals that support a Dr. Peter J. Stern 20th Century Fox Buffalo Wild Wings Society event. Harry and Jo Ann Stoddard Accenture Cadell Dry Dock & Repair Co., Inc. $100,000 – $499,999 Sheryl Stollof Acquest Development Calyon Financial, Inc. American Airlines Keith D. Stoltz Foundation ADC Can-Am Contractors American Bicycle Association The Strain Foundation AgVar Chemicals, Inc. Capital Automotive REIT Bristol-Myers Squibb Company Sugar Lakes Foundation Akin, Gump, Strauss, Hauer Capital One Services, Inc. Computer Associates Dave C. Swalm & Feld LLP CapitalSource, Inc. Disney Worldwide Services Swing For a Cure Alcalde & Fay Cardservices International, Inc. Finish Line J.T. Tai & Co Foundation, Inc. Mr. Pat Allender Ronald Carr Foundation Genentech Donald and Tracey Tandy Alston & Bird Carrella, Byrne, Bain, Gilfillan, MCG Capital The Taylor Family Foundation AMDOCS Cecchi, Stewart & Olstein Mercedes-Benz USA LLC Mr. and Mrs. Gillis Thomas Amgen, Inc. Carter’s Motive, Inc. Mary Lou Timpson Anning-Johnson Company Carter BloodCare Nike TJX Companies, Inc. Anonymous Daniel S. Catalfumo Family Ortho Biotech Foundation TrimQuest Anteon International Corporation P.F. Chang’s China Bistro CBRE CB Richard Ellis/L.J. Melody Mr. and Mrs. Robert Tschudy AOR Management Company Capital Markets PowerBar Two Sisters Gourmet Apache Corporation CB Richard Ellis – Corporation Runner’s World Ronald and Arleigh Tysoe Ariel Mutual Funds Services Seagate Technologies Marilyn Underhill Arizona Public Service Celgene Corporation Williams & Connolly LLP United Way of Delaware Arnold & Porter LLP Cell Therapeutics, Inc. Aronson & Company United Way of New York City $50,000 – $99,999 Centerplate NBSE Mr. LaVar Arrington Mr. and Mrs. Ron and Terry Unkefer Mr. and Mrs. Melvin D. Booth Chain Bridge Capital LLC ASI The Valentine Foundation Comcast Chiron AstraZeneca Vanguard Charitable Endowment / DE Corixa CIBC World Markets AT&T E P Vaughhan Beneficiaries Cumberland Packing Corporation Crowe Chizek c/o US Bank Aureus Lawrence J. DeGeorge and Florence Citigroup Verizon Foundation A. DeGeorge Charit BAE SYSTEMS Citizens Bank Victory Scramble Fore A Cure Encounter Care Solutions, Inc. Bank of America The Cleveland Clinic Foundation Vredenburg Foundation Energy2Cure Banc of America Securities LLC Clif Bar Marc Walfish Genentech BioOncology Bank of Tokyo-Mitsubishi Mr. Christopher Cline The James and Debra Wallace GlaxoSmithKline Barry Kaye & Associates Mr. George Cloutier Foundation Hargrove, Inc. bcgi Kathy and Gary Coates Watkins Family Charitable Fund IEP/MPG BearingPoint, Inc. Cole Haan Wholesale WaWa, Inc. Ms. Nancy S. Itteilag Beers & Cutler Comcast Cable Wechsler/Marsico Associates Laborers’ Charitable Foundation Berlex Compass Bank The Harry & Jeanette Weinberg Lunardi’s Market Berlex Oncology Foundation, Inc. Corporate Express Business Interiors Michael McCarthy Foundation Bert Smith & Co. Mr. Robert Weiss Costco Nemacolin Woodlands, Inc., Mr. and Mrs. Eric Billings The Western and Southern Life Countrywide Home Loans 84 Lumber Company & The Hardy Insurance Company Biogen Idec The Crean Foundation Family Trust M&M Whitmire Family Foundation Blue Cross Blue Shield of Mississippi Credit Suisse First Boston Nestle FoodServices Wichita Community Foundation Booz Allen Hamilton, Inc. Mr. Ferdinand J. Crovato 2 Nextel Communications, Inc. 005 Mr. and Mrs. Jack Wilson Borgata Heart and Soul Foundation Crowell & Moring LLP The Sallie Mae Fund Mr. and Mrs. James F. and Judith Bouchard Coastwise Management Cruise Industry Charitable | Sunsail AN Watts Wilson Corporation Foundation SuperGen, Inc. Bouchard Transportation Co., Inc. N Wipe Out Leukemia Forever Cub Foods Bridgeview U

Toyota AL Foundation, Inc. Aaron Braun Cub Foods Elston Tom Woods Memorial Foundation West Marine Brayton Purcell R Cub Foods Freeport EPOR Western Asset Management Wyeth Pharmeceuticals Bridgecom International Cub Foods Joliet South Windward Homes Mrs. Dee Sanfilippo Mr. and Mrs. Peter and Janice Brock Cub Foods Regional Office T Wyner Stokes Charitable Trust Woodbine Entertainment Group Frank G. and Frieda K. Brotz Family 23 Mark Zurack Foundation, Inc. sponsor partnerships continued

Danaher Corporation GEICO Macy’s Peninsula Cancer Institute DARCARS General Dynamics Maguire Properties PEPCO Dave Walters Company General Motors Corporation Makar Management LLC Mr. Richard Perlman Dean Walters Companies Charles Gibbs, Jr. Manning Selvage & Lee Peterson Aluminum Corporation Decathlon Club Ms. Patricia Gioia Manugistics, Inc. Pfizer Degenstein Foundation GMAC E.O. M & D Maryland State Council Knights PGA Tour Superstore Delta Airlines Goldman Sachs & Co. of Columbus PGT Trucking, Inc. Deloitte Greenwich Capital Markets Masonite International Corporation Plumbers & Pipefitters Local Mr. John Derose Robert Gustafson MCG Capital Corporation Union 72 Deutsche Bank The Tom Merit Hancock Family Fund MedImmune, Inc. PNC Advisors DEX Handleman Company Medline Industries PPD Development LP Dingbats & Abate Restaurants Paul Handlerly Mellon Bank Prairie Farms Discovery Networks, U.S. A.L. Hanford Memorial Fund Mercedes-Benz of Greenwich Prairie Meadows DLA Piper Rudnick Gray Cary Harkins Builders Merrill Lynch & Co. Precision Communications US LLP Harris Private Bank Microsoft Corporation Price Modern Dominos Hazmet Environmental Mighty Taco PricewaterhouseCoopers LLP Dresser Flow Solutions Hewitt Associates Millennium Pharmaceuticals, Inc. Protiviti Duffy Mechanical Corporation Hewlett Packard Mills Limited Partnership Pulse EFT Association Duquesne Light Highmark, Inc. MK Real Estate Group, Inc. PVS Chemicals, Inc. E*TRADE Financial HITT Contracting, Inc. Mr. and Mrs. Alfred T. Mockett Dr. and Mrs. Richard Raizman Easterns Automotive Group Howard Capital Management, Inc. Mohegan Sun RBC Foundation EDS an E*Trade Co. Mondavi Realty Capital Partners EFW, Inc. Howard County General Hospital Morris Levine Key Food Stores or Herndon LLC James L. Eichberg Foundation Hy-Vee, Inc. Foundation, Inc. Mr. Allen B. Rector Eli Lilly & Company Ilex Oncology Motorola RE/MAX Harbor Realty El Paso Corporate Foundation Independence Air Mount Gay Rum Reliable Churchill LLP Employees of FBR Indianapolis Power & Light Munger, Tolles & Olsen Mr. and Mrs. Bruce Rendina Enterprise Rent-A-Car Industrial Alliance Pacifice Mylan Charitable Foundation Riverside Health System Foundation Epsilon Insulators Health Hazard Fund National Commercial Flooring Robert E. Torray & Company Equifax, Inc. The International Society National Cooperative Services Royal Bank of Scotland Corporation Ernst & Young LLP Jackson Lewis LLP Rural Telephone Finance Cooperative National Rural Utilities Cooperative Ernst & Young LLP Transaction JFK Medical Center Safeway Finance Corporation Advisory Services Jim Koon’s Automotive Companies San Francisco Bay Area Labor National Trade Productions ESP-Pharma JP Morgan Chase & Co. SAP Neiman Marcus Esprit Events, Inc. Kaelin Family Captain’s Cup Satterfield & Pontikes NeuStar, Inc. FedEx Corporation Kaiser Permanente SBC Communications, Inc. NewMarket Corporation Fidelity National Title Agency Mr. and Mrs. Alexander L. Scheer Partners, Inc. New Quest Properties Figg Engineering Group Karakozoff Schumacher Family Foundation, Inc. Niello Company First Niagara Bank K-Designers Scotia Capital Northrop Grumman Fisher Investments Kekst & Company, Inc. Sewell Cadillac Novartis Oncology FishHawk Ranch KPMG LLP Joseph Sheairs Associates, Inc. Novartis Pharma Canada, Inc. Foodland Supermarkets Kroger Siemens NVR, Inc. Samuel J. and Connie M. Frankino KST Data, Inc. Silicon Valley Bank Octagon Charitable Foundation Lakefront Communications, Inc. Simpson Thacher & Bartlett LLP Oncology Therapeutics Network Fried, Frank, Harris, Shriver LaSalle Bank SK Worldwide & Jacobson Oracle Corporation Lehman Brothers, Inc. Skyy Spirits LLC Mr. Emanuel J. Friedman Ortho-Biotech L.E.K. Consulting LLC Slawson Cunningham & Whalen PL Friedman French Foundation Owen Pharma Linebarger, Goggan, Blair, Pena Slumberland Future Tech Enterprises, Inc. Panera Bread of Central Illinois & Sampson LLP Smart Choice Settlements Gary Martin Hays and Parade Lockton Companies Smith Barney Citigroup Associates, PC Paymentech M&T Bank Sony DADC 24

promotion partnerships

Southern California Edison Weitz & Luxenberg PC Promotions are individuals or Charter One Bank institutions that organize an event Mr. and Mrs. Mark Spisak Wells Fargo The Classic Catering People and donate proceeds to the Society. Sprint Westin Santa Clara Coinstar $1,000,000 and above St. Joseph’s/Candler Wheeler Family Foundation CWP Asset Corp. DBA Mister KGO Newstalk AM 810 SteelFab Mr. and Mrs. Stuart Williams Car Wash Department 56 Stock Development LLC Williams & Connolly LLP $500,000 – $999,999 DEX Kilpatrick Stockton Wilmer, Cutler & Pickering Hale DialAmerica Marketing, Inc. and Dorr LLP Dominos StructureTone, Inc. Verizon Sun Microsystems, Inc. WIN WIN Strategies Foundation Father Serra C.S. $100,000 – $499,999 Sun Trust Banks, Inc. WIVB-TV, Channel 4 Fox 5/UPN20 A&P/Super Fresh Supermarkets Sun Trust Marine Lending Yellow Corporation Freedom Valu Centers ABC 7 Systems Connection of Maryland XM Satellite Radio Jack Moore Memorial Golf Burlington Coat Factory Tournament Target Computer Associates International, KTWV 94.7 The Wave Tech Village Partners LLC Inc. The McCormick Tribune Foundation Thelan, Reid & Priest LLP Cub Foods East Media/Professional Insurance Thompson, Habib & Denison Equifax Members 1st F.C.U. ThoughtWorks The Olive Garden Italian Restaurant Menkes Ltd. Developments Edgar A. Thronson Foundation, Inc. Radio Disney AM 1110 Mrs. Fields Cookies Title, Inc. Ruth’s Chris Steak House – Baltimore Option One Mortgage Robert E. Torray & Company Sports Radio 1130 WDFN Randstad, North America Toyota St. Valentine’s Day Luncheon and RBC Dominion Securities Inc. Turner Construction Company Style Show The Regence Group Turner Interiors Team Friends of Allie – Honoring Ride of Dreams UBS Investment Bank Sam Eisenberg and Allie Scott S & T Enterprises, Inc. UF & Shand’s Cancer Center Windward Homes San Par Leukemia Benefit UNISYS WYAY EAGLE 106.7 Sheraton Gateway United Jewish Endowment Fund $50,000 – $99,999 Shula’s, Inc. University Hospital BIG 100.3 The Susquehanna Ski University Hospitals Health System Booz Allen Hamilton and Snowboard Club Ireland Cancer Center Clear Channel Vibro-Acoustics University of Pittsburgh Medical Center CompUSA Volvo of Mississauga Versailles Ohio Poultry Days Great American Insurance Company Waddell & Reed Ultimate Frisbee Tournament Washington Business Journal $10,000 – $49,999 Virginia Mason Medical Center WIVB-TV, Channel 4 Airdrie Optimist Club Volvo of Savannah Wisconsin Public Service Arby’s Wachovia Corporation (First Union) Austaco – Taco Bell Wachovia Securities Bergstrom Automotive Washington Building & Construction Trades Council Bowne & Co., Inc. Washington Express Luc and Maria Boisclair – In Memory of Alex Washington Gas

Washington Nationals 2 005 Washington Redskins Leadership

Council |

National Man & Woman of the Year AN Waste Management

Jim Morrison N

Waterfront Properties, Inc. U

Lizzy Walker Conroy AL Watson Wyatt Worldwide R

WCI Communities EPOR The Harry & Jeanette Weinberg

Foundation Incorporated T

25 the legacy circle

The Legacy Circle honors those Pasquale R. Cheche David Frantze Dwayne Howell who have included the Society Thomas Cheek Jon Freitag Barbara Hufford in an estate plan. David E. Cherry Paul N. Frimmer Heather Hunt Hugh Albora Christina Clapham Roberta Fuhr Dr. Brian Hurley Peter Alexas Sylvia Clemetson Albert and Gladys Gardner William Ianniello Bruce Allen Paul and Nancy Clendening Marian Genarro Charles F. Inglefield Fay Allen Denise Coats Anna Maria Gentile Deborah Jaskulski Margaret H. Anderson Wayne Cope John A. Geoghegan Mrs. Lily Marie Jeffreys Marjorie Anderson Michael and Liz Copley Richard and Jacqueline Geswell Anne K. Johnson Debra Andrade Michelle Cromwell Patricia Ghiglieri Harry and Donna Johnson III Mr. and Mrs. David Andrews Katherine Wageman-Cook Douglas Gilbert Kristen Johnson James and Eileen Andrews Dr. Anthony Cortese Noreen L. Giese Mrs. Darden Jones Kristi Anys Marianne Cotter Heather Girard Dan and Leslie Jordanger Estate of Louise K. Archer Raymond Cox Wade Goehring John and Judith Kamins Lucy Attner Steve R. Craig and Susan Laine Jacob and Sara Gold Patricia Kay Lorae P. Aumack Marilyn J. Crohan Richard Goldberg Nathan and Ruthie T. Katz Minnie Austin Lydia D’Agosto Wilma Gottlieb Michael E. Keefe Mr. and Mrs. Jay Barrows Edmund D’Allesio Miss Barbara Grace Mr. and Mrs. Christopher J. Kearns John Bashta Judy Davis Rebecca Ann Grajewski John B. Kelly Mr. and Mrs. Edwin J. Beckley, Jr. Robert D. Dean Ruth Granat * Michael Kerper Angelo Bardi Dr. and Mrs. Michael L. Dean Carol Grandaw Frances Keating Ruth Bartlett Carolyn Dee Mr. and Mrs. Forrest Grosvenor Annabelle King, MD Claudia and Stephen Barto, Jr. David and Connie Dimling Dan and LaDonna Gubitz Sue Kinney-Wieland Margaret Beers Kathy Dirckx Carter K. D. Guice, Jr. T. Corey Kipp Dennis Beardsley Dorothy Dootson John Haluck Monica Klapper Ryan Beagin Joel Drake Mr. and Mrs. Ken Haller Susan Kobrel Steven R. Bender Harry and Barbara Dunlap Liliana Hamilton Karl Koepke Ami Berkowitz John Dunn Keith P. Harenda Jeff and Teresa Kopietz Clyde S. and Rosie Billman Timothy S. Durst Joan Haratani Carmella Kramer Alexandra Mayes Birnbaum Agnes Dury Alice Hatch Mark and Christine Kraemer The Stephen Birnbaum Foundation George F. and Evelyn Eckhardt, Jr. Pat Hauer Leslie Elliot Krause, Esq. Margaret Black Clif Edwards Kathleen Hays, RN, MSN Marjo Kremko Richard Blond J. Stephen Eickert Donald P. Heim R. Scott Krizek Christopher Blum * Greg Elfers Tom and Wendy Henry Mr. and Mrs. Greg Kulm Lori Blum Mr. and Mrs. Jeffrey Ellena Dr. Saul Highman Janna LaCock Sally Blume Judith Erickson Catherine E. Hildreth Janet LaVere Robert H. and Janet Bohannon Dr. George A. Farber, Sr. Leila Hittinger John Lamb, Jr. James Bolton Lynne E. Fazzi C. Brooks Hoffman Lucy Lang Mart Bort Arnold Feldman William Hoffman Alan P. Laskin William Boyd Harold Fennell Carol Hogan William S. Lear Irvin B. Braverman, MD Harvey Fernbach, MD Fay Holzman Diana Lynn Lee Wilburn Brewer, Jr. * Richard Fess Courtney and Robin Hollar Gail M. Lee Judith Arner Brown Helen F. Fisher * Mr. and Mrs. Steven Hooker Joseph Lee Richard Cahill Deidre Fitzpatrick Jacqueline Hood Kelli Leffingwell Scott A. Carroll Thomas L. Fitzpatrick Jeanie Hoover * Lon Leneve Jennifer Caves The Honorable Ronald A. Fonseca Lynn C. Hoover Paul L. Lewis Mary Carver Charles and Evelyn Foster Beth Hoth Robert Lindsey Colon B. Carter Mr. and Mrs. James T. Fox John Harrison Hough Harvey and Linda Litofsky Robert Charon Leo Frank Roy Hovinen Geoffrey Lombard 26 the legacy circle continued

Mr. and Mrs. F. F. Michael Lynch Edward D. O’Malley Lorraine Seidel Dr. Vicque L. Walton-Kimmel Eric and Becky Mahlum Mrs. Harry O’Toole David A. Schick Beverly G. Warner Ida Malena Margaret Olmazu Maya B. Shenoy Louise Warner Georgia Davidis Malone George Omiros Norman and Katrine Shorb Philip F. Warner Maria Maramag Rosemary Opbroek Frank T. Short Paul Weiden, MD Dr. and Mrs. Stanley N. Marks Mary J. Oyer Frank Sidwell Phyllis Weil Greg Martin Jacqueline Anne Palmenberg Norbert J. Sieber Deborah Weinstein William Martin Frederic and Wannelle Parvey Jay and Elaine Silver James A. Weinberg Mark E. Mason Rosa Pena Linda Sims Paul and Annie Weiss Joan Maves Stephen M. Peters Tena Simmons W. Russell Welsh Robert and Marnee Maylone Mr. and Mrs. David L.Pfeifle Irene Skomro Mr. and Mrs. John Wempe Rita Meek, MD Leslea S. Pidgeon Rose Slotsky Steven Wescoatt Rhonda Meeks William Pike Mary-Gail Smith Larry and Kathleen Wheaton Timothy and Susan Metzer Lisa Pirrung Mr. and Mrs. Robert Smith Dr. and Mrs. Stanley A. White John and Patty McDonald Ginette Poitevent Russell D. Smith Carl and Hillary Whitley Thomas and Olive McDonald George Pooley * Nicoma Sobolewski Don Wier Dorothy McCann Mr. and Mrs. Chris Post Jeffrey and Angela Solomonson Stephen and Terri Williams Marilyn McFadden Leila Elizabeth Presniak John C. Sorrell Anthony and Michelle Wong Sylvia McGovern Mr. and Mrs. Michael Price Elda Spano Clara Wood Carolyn E. McKown Larry Pyles James E. Sparkes Laura B. Worsham Mr. and Mrs. Clayton McPhail David B. and Toni Quinty Barbara A. Spiegel Mr. and Mrs. Douglas Young Anthony McPherson Marty Rauch Thomas and Joanne Spink Joseph Yurfest Lisa A. Mihalik Diane Raymond Mark and Carol Spisak Ed Yurowksi Paul Hart Miller Richard and Kathy Reader Darrin Sprilczuk * Violet Yurowski * Tina Marie Milligan Helen Doss Reed Carole Stadfield Thomas and Anne Zak Suzy Minkoff Larry E. Reinart Inez Star Mr. and Mrs. Scott Zeilinger Joshua Mitchell, MD Ernestine Reinert Richard Steffen Katherine Zell-Cherry Ted Mociun James Relkin Fred and Simone Stella Mrs. Ruth Zyskowski Michael and Tammy Moloy David Rice * Paula and Phillip Stone Dennis F. Moore, MD Marilyn Richardson Brian J. Stumm Joann Moran Joseph Russell Marcie Summerlin Mr. and Mrs. Thaddee F. Moreau Donald G. Rigoni Dolores Swirin Dennis Morris Ernest Riise Merideth Tall James Morton Gary and Becky Roberts Stewart Teichman Robert J. Moyle Judith A. Ross Gracie Thompson Frank Mungo Mrs. Syril Rubin Patricia Trosclair Suzanne J. Muntzing Seth and Carolyn Rudnick Joe and Lorraine Tumolo Oscar Muskopf Kevin R. Ryan Heather Turnbull Rodman N. Myers Victor and Jacqueline Sacco Paul and Debra Vaughn Robert J. Myette William H. Sachs Joseph and Karen Verdirame

The Honorable Robert H. Newman Robert M. Sanders Bert Vignes 2 005 Tracy Newman Dee Sanfilippo Laura Walker

Robert C. Niles Thomas J. Scanlon Mr. and Mrs. Rubin Wallach | AN Regina Nizzoli David and Barbara Schaefer Michael Walrath * Anonymous (224) N

Edward Nofer III Karl Schaeffer Michael E. Walsh Members as of June 30, 2005 U AL Jason North Ken Scherzer Dr. Robin Walsh * Deceased R

Richard F. Nourie Patrick Schmidt John E. Walter EPOR Jeanne Null Eugene Schmitt * Kimberly Walton

Carolyn and Jerry O’Hara Deborah Scott-Ensley Phyllis J. Walton T 27 independent auditors’ report

The Board of Directors The Leukemia & Lymphoma Society, Inc.:

We have audited the accompanying consolidated statement of financial position of The Leukemia & Lymphoma Society, Inc. (the Society) as of June 30, 2005, and the related consolidated statements of activities, cash flows, and functional expenses for the year then ended. These consolidated financial statements are the responsibility of the Society’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit. The prior year summarized comparative information has been derived from the Society’s 2004 consolidated financial statements and, in our report dated October 1, 2004, we expressed an unqualified opinion on those statements.

We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Society’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of The Leukemia & Lymphoma Society, Inc. as of June 30, 2005, and the changes in its net assets and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

September 30, 2005 New York, NY

28

consolidated statement of financial position

The Leukemia & Lymphoma Society, Inc. June 30, 2005 (with comparative amounts at June 30, 2004) (in thousands)

2005 2004 Assets Cash and cash equivalents $ 6,116 $ 22,703 Accounts receivable 672 555 Legacies and contributions receivable (note 2) 5,026 5,347 Prepaid expenses 4,246 4,024 Investments, at fair value (note 3) 131,770 83,653 Fixed assets, less accumulated depreciation and amortization of $7,594 and $6,289 4,098 3,624

Total assets $ 151,928 $ 119,906

Liabilities and Net Assets Liabilities: Accounts payable and accrued expenses $ 17,667 $ 13,039 Deferred revenue 10,755 6,795 Grants payable (note 4) 56,774 46,613 Total liabilities 85,196 66,447

Net assets: Unrestricted 59,574 46,674 Temporarily restricted (note 7) 4,495 4,465 Permanently restricted (note 7) 2,663 2,320 Total net assets 66,732 53,459

Total liabilities and net assets $ 151,928 $ 119,906 2 005 | AN N U AL R EPOR T

See accompanying notes to consolidated financial statements. 29

consolidated statement of activities

The Leukemia & Lymphoma Society, Inc. Year ended June 30, 2005 (with summarized totals for the year ended June 30, 2004) (in thousands)

Temporarily Permanently Total Unrestricted Restricted Restricted 2005 2004 Revenue Campaign contributions $ 225,380 $ 10,782 $ – $ 236,162 $ 201,104 Less direct donor benefit costs (32,620) – – (32,620) (28,394) Net campaign contributions 192,760 10,782 – 203,542 172,710 Legacies 4,599 72 89 4,760 2,462 Donated services (note 1) 4,205 – – 4,205 – Net interest and dividend income (note 3) 2,632 65 – 2,697 841 Net increase (decrease) in fair value of investments 2,711 (18) 15 2,708 3,256 Grant refunds 653 – – 653 881 Net assets released from restrictions 10,999 (10,999) – – – Total revenue 218,559 (98) 104 218,565 180,150

Expenses (note 8) Program Services: Research 54,037 – – 54,037 42,899 Patient and community service 58,821 – – 58,821 46,603 Public health education 32,598 – – 32,598 28,540 Professional education 9,846 – – 9,846 9,071 Total program services 155,302 – – 155,302 127,113

Supporting Services: Management and general 16,225 – – 16,225 14,048 Fund raising 35,161 – – 35,161 30,508 Total supporting services 51,386 – – 51,386 44,556

Total expenses 206,688 – – 206,688 171,669

Excess (deficiency) of revenue over expenses 11,871 (98) 104 11,877 8,481 The Leukemia & Lymphoma Society of Canada (“LLSC”) net assets as of July 1, 2004 (note 1) 1,029 128 239 1,396 –

Change in net assets 12,900 30 343 13,273 8,481

Net Assets Beginning of year 46,674 4,465 2,320 53,459 44,978 End of year $ 59,574 $ 4,495 $ 2,663 $ 66,732 $ 53,459

30 See accompanying notes to consolidated financial statements.

consolidated statement of cash flows

The Leukemia & Lymphoma Society, Inc. Year ended June 30, 2005 (with comparative amounts for the year ended June 30, 2004) (in thousands)

2005 2004 Cash flows from operating activities: Change in net assets $ 13,273 $ 8,481

Adjustments to reconcile change in net assets to net cash provided by operating activities:

Net assets of LLSC at merger (1,396) – Net increase in fair value of investments (2,708) (3,256) Permanently restricted revenue collected (89) (928) Depreciation and amortization 1,186 1,209

Changes in assets and liabilities:

Increase in accounts receivable (78) (173) Decrease in legacies and contributions receivable 321 1,726 Increase in prepaid expenses (197) (587) Increase (decrease) in accounts payable and accrued expenses 4,520 (251) Increase in deferred revenue 3,848 1,504 Increase in grants payable 9,325 2,911 Net cash provided by operating activities 28,005 10,636

Cash flows from investing activities: Purchases of fixed asstes (1,244) (937) Purchases of investments (202,996) (70,733) Sales of investments 158,310 51,115 Net cash used in investing activities (45,930) (20,555)

Cash flows from financing activities: LLSC cash at merger 1,249 – Permanently restricted revenue collected 89 928 Net cash provided by financing activities 1,338 928

Net decrease in cash and cash equivalents (16,587) (8,991) Cash and cash equivalents at beginning of year 22,703 31,694

Cash and cash equivalents at end of year $ 6,116 $ 22,703 2 005 | AN N U AL R EPOR T

See accompanying notes to consolidated financial statements. 31 consolidated statement of functional expenses

The Leukemia & Lymphoma Society, Inc. Year ended June 30, 2005 (with comparative totals for the year ended June 30, 2004) (in thousands)

Program Services Supporting Services Direct donor Patient and Public Management Total benefitDirect costsdonor community health Professional and Fund Total benefit costs Research service education education Total general raising Total 2005 2004 2005 2004

Awards and grants $51,310 $ – $ – $ – $51,310 $ – $ – $ – $51,310 $41,084 $ – $ – Financial aid to patients – 4,505 – – 4,505 – – – 4,505 4,020 – – Donated services 533 3,672 – – 4,205 – – – 4,205 – – – Salaries 557 23,277 10,749 4,396 38,979 5,964 7,881 13,845 52,824 43,612 – –

Employee benefits and taxes (note 5) 99 4,903 2,660 1,057 8,719 1,345 2,132 3,477 12,196 10,583 – – Occupancy 22 2,684 1,524 638 4,868 793 1,117 1,910 6,778 6,423 – – Insurance 10 243 167 52 472 73 162 235 707 650 – – Telephone 17 1,059 745 167 1,988 232 1,144 1,376 3,364 3,079 – – Travel 26 1,052 574 243 1,895 332 413 745 2,640 2,100 11,760 10,859 Printing and supplies 196 4,345 5,835 877 11,253 2,523 7,704 10,227 21,480 20,428 5,758 5,070 Equipment rentals and maintenance 14 811 474 188 1,487 239 387 626 2,113 1,841 – – Postage and shipping 75 2,336 3,756 541 6,708 1,218 5,578 6,796 13,504 11,993 – – Meetings 591 1,762 852 323 3,528 408 531 939 4,467 3,492 7,331 5,906 Professional fees 560 7,316 4,750 1,166 13,792 2,798 7,683 10,481 24,273 19,978 3,608 2,945 Miscellaneous 12 441 234 107 794 174 168 342 1,136 1,177 4,163 3,614 Depreciation and amortization 15 415 278 91 799 126 261 387 1,186 1,209 – –

Total expenses $ 54,037 $ 58,821 $ 32,598 $ 9,846 $155,302 $ 16,225 $ 35,161 $ 51,386 $206,688 $171,669 $ 32,620 $ 28,394

See accompanying notes to consolidated financial statements.

program services expenses 37.9%

Research 34.8%

34.8% Patient and Community Service 37.9%

Public Health and Professional Education 27.3% 27.3%

32 notes to consolidated financial statements

The Leukemia & Lymphoma Society, Inc. Year ended June 30, 2005 (with comparative amounts as of and for the year ended June 30, 2004)

1. Organization and Significant Accounting Policies Permanently restricted net assets: Consist of funds that contain donor-imposed restrictions requiring that the Organization principal be invested in perpetuity and that only the income The Leukemia & Lymphoma Society, Inc. (the “Society”) is be used. Income earned on these funds may be unrestricted an international not-for-profit health agency dedicated to seeking or temporarily restricted, depending upon the donor-imposed the cause and cure of leukemia, lymphoma, Hodgkin’s disease restrictions. and myeloma and improving the quality of life of patients and their families. The Society’s principal activities include: awarding Contributions and Deferred Revenue research grants; facilitating psychosocial support groups; providing Contributions are recorded as revenue, at their fair value, financial aid to patients; answering phone requests for blood- when received or promised unconditionally. Contributions related cancer information made to the Society’s Information received with donor restrictions that limit their use are reported Resource Center; and disseminating educational information as either temporarily or permanently restricted revenue. about blood-related cancers in the form of publications, internet When a donor restriction is met through the passage of time sites, conference calls and symposia sponsorship for both the or fulfillment of a purpose restriction, temporarily restricted medical community and the general public. net assets are reclassified to unrestricted net assets and reported in the statement of activities as net assets released from The Society entered into a merger agreement with Leukemia restrictions. Conditional contributions are recognized as Research Fund of Canada (“LRFC”), effective July 1, 2004, under revenue when the conditions have been substantially met. which the Society has approval rights over all LRFC resolutions. As part of this agreement, the name of LRFC was changed Deferred revenue includes amounts received for special events to The Leukemia & Lymphoma Society of Canada, Inc. (“LLSC”). that will be held subsequent to the fiscal year-end. The merger was accounted for in accordance with purchase Donated Services method concepts whereby a contribution of LLSC’s net assets In 2005, the Society determined that certain of the donated (at fair value) was recorded by the Society. services it received met the criteria for recognition in the financial Tax-Exempt Status statements. Specifically, the donated services of family support The Society qualifies as a charitable organization as defined group facilitators and research grant reviewers have been valued by Internal Revenue Code Section 501(c)(3) and, accordingly, and are reported as both revenue and expense in 2005. Since is exempt from federal income taxes under Internal Revenue there is no impact on the reported change in net assets, the Code Section 501(a). Additionally, since the Society is publicly- Society has not retroactively recorded these donated services in supported, contributions to the Society qualify for the maximum 2004. Society management believes the value of donated services charitable contribution deduction under the Internal Revenue in 2004 was comparable to that in 2005. Code. Cash Equivalents LLSC is registered as a charitable organization under the Income Cash equivalents consist of short-term investments with Tax Act (Canada) and is therefore not subject to income taxes a maturity of three months or less from date of purchase, except if certain disbursement requirements are met. for amounts held for long-term purposes reported as investments. Principles of Consolidation Fixed Assets and Depreciation The accompanying consolidated financial statements include Fixed assets, which consist principally of equipment and the accounts of the Society, which encompasses the Home Office leasehold improvements, are recorded at cost, if purchased, or at of the Society and its sixty three chapters, LLSC, and the Society’s fair value at date of donation, if contributed, and are depreciated not-for-profit affiliates, The Leukemia & Lymphoma Society or amortized using the straight-line method over the estimated Research Programs, Inc. and The Leukemia & Lymphoma useful lives of the assets or the terms of the leases, if shorter. Society Research Foundation. All significant inter-company Estimates and intra-Society accounts and transactions have been eliminated The preparation of financial statements in conformity with in consolidation. generally accepted accounting principles requires the Society’s Net Asset Classifications management to make estimates and assumptions that affect the To ensure observance of limitations and restrictions placed on amounts reported in the financial statements and accompanying the use of resources available to the Society, funds that have notes. Actual results could differ from those estimates. similar characteristics have been classified into three net asset Summarized Financial Information categories as follows: The financial statements are presented with 2004 summarized 2 Unrestricted net assets: Consist of funds that are fully or comparative information. With respect to the statement 005 available, at the discretion of the Board of Directors, for the of activities, such prior year information is not presented by net

assets class and, in the statement of functional expenses, 2004 |

Society to utilize in any of its programs or supporting services. AN expenses by object are presented in total rather than by functional

Temporarily restricted net assets: Consist of funds that are category. Accordingly, such information should be read in N restricted by donors for a specific time period or purpose, as U

conjunction with the Society’s 2004 consolidated financial AL well as amounts relating to term endowment or deferred giving statements from which the summarized information was derived. arrangements in which the funds must be maintained intact R EPOR over the lifetimes of the donors. T

33 notes to consolidated financial statements

2. Legacies and Contributions Receivable 5. Pension Plan

The Society’s legacies and contributions receivable at June 30, 2005 The Society has a noncontributory, defined contribution 403(b) and 2004 consist of unconditional promises to give and legacies pension plan covering all employees meeting age and service for which the underlying wills have been declared valid by the requirements. Contributions are based on a percentage of each probate court and no other conditions are required to be met. eligible employee’s salary and years of service. Expense under this Amounts are scheduled to be received as follows (in thousands): plan aggregated $2,327,000 and $2,194,000 for the years ended June 30, 2005 and 2004, respectively. 2005 2004 Less than one year $ 4,795 $ 5,020 6. Lease Commitments 1 to 5 years 256 351 The leases for premises which the Society’s Home Office and 5,051 5,371 chapters occupy expire on various dates through December 31, 2012 and provide for certain payments subject to escalation Less discount to present value and periodic rate increases relating to real estate taxes, operating (discount rate – 5%) (25) (24) expenses and utilities. Total $ 5,026 $ 5,347 The approximate minimum future annual rental commitments are summarized as follows (in thousands): 3. Investments Year ended June 30: 2006 $ 6,146 The following is a summary of investments at June 30, 2005 and 2007 5,722 2004 (in thousands): 2008 5,122 2005 2004 2009 4,427 Cost or Cost or Donated Fair Donated Fair 2010 4,527 Value Value Value Value Thereafter 1,535 Money market funds $ 48,876 $ 48,876 $ 24,874 $ 24,874 Total $ 27,479 Corporate notes and bonds 19,421 19,466 12,999 13,027 Common stocks and mutual funds 28,251 30,779 26,853 28,310 7. Temporarily and Permanently Restricted Net Assets U.S. Government obligations 27,605 27,698 17,383 17,384 Temporarily restricted net assets and the income earned on Other 4,771 4,951 58 58 permanently restricted net assets are available for the following purposes at June 30, 2005 and 2004 in thousands): Total $128,924 $131,770 $ 82,167 $ 83,653 2005 2004 Temporarily Permanently Temporarily Permanently Debt and equity securities are recorded at fair value as determined Restricted Restricted Restricted Restricted by quoted market prices. Mutual funds are recorded at fair value Research program $ 2,810 $ 2,616 $ 3,578 $ 2,273 using published unit values. Investment expenses of $284,000 and Patient service and $281,000 have been netted against interest and dividend income bone marrow donor programs 255 – 215 – for the years ended June 30, 2005 and 2004, respectively. Professional education program 24 47 23 47 4. Awards and Grants Other programs 1,406 – 649 –

Awards and grants for research are recognized as expense Total $ 4,495 $ 2,663 $ 4,465 $ 2,320 in the year approved by the Society’s Board of Directors. Multi-year grants, which are generally two to five years in length, are approved on an annual basis and may be terminated at the 8. Joint Costs Allocation discretion of the Society’s Board of Directors. In addition to In 2005 and 2004, the Society incurred joint costs for informational unconditional grants payable of $56,774,000 at June 30, 2005, materials and activities that included fund raising appeals as follows the Society has grant commitments of $90,345,000 that are (in thousands): conditioned upon future events and, accordingly, are not recorded. 2005 2004 Fund raising $ 14,166 $ 12,225 Patient and community service 1,612 1,446 Public health education 8,616 7,675 Total $ 24,394 $ 21,346

34 national leaders

Chairman of the Board Board of Directors John B. Kelly Kevin R. Ryan Capitol Financial Group Yampolsky, Mandeloff, Silver & Co. John M. Kamins Alexandra Mayes Birnbaum Sacramento, CA Philadelphia, PA Honigman Miller Schwartz and Cohn Peartree Communications, Inc. New York, NY Detroit, MI Leslie Elliot Krause, Esq. Maya B. Shenoy Law Offices of Leslie Elliot Krause Charlotte, NC Vice Chairman for Medical and Robert A. “Spider” Cantley New York, NY Scientific Affairs Twainharte, CA Frank T. Short Michael W. Long, PhD Short Strategy Group, Inc. Beverly S. Mitchell, MD Paul J. Cienki Cancer Research Center Velcura Therapeutics, Inc. Indianapolis, IN General Dynamics Network Systems Stanford University Ann Arbor, MI Needham, MA Stanford, CA Norbert J. Sieber Dennis F. Marco MARC USA Michael Copley North Haledon, NJ Miami, FL Vice Chairman for Field Relations Children’s Hospital & Health Center San Diego, CA David Frantze W. Stratford May, Jr., MD, PhD Jay L. Silver Stinson, Mag & Fizzell, PC University of Florida Sugar Land, TX Lawrence D. Ellis, MD Kansas City, MO Gainesville, FL University of Pittsburgh Thomas R. Snyder Pittsburgh, PA Vice Chairman for Patient Services Thomas R. McDonald Nashville Bank and Trust Marana, AZ Nashville, TN Marie Lauria, MSW Paul N. Frimmer Chapel Hill, NC Irell & Manella, LLP Richard H. Michalik James E. Sparkes Los Angeles, CA Vice Chairman for Resource Naperville, IL Sugarman Law Firm, LLP Syracuse, NY Development John A. Geoghegan Rodman N. Myers Gellert & Quartararo, PC Margaret H. Anderson Honigman Miller Schwartz and Cohn James J. Stephanak Purchase, NY Anderson, Bryant, Lasky Detroit, MI The Kalamazoo Gazette & Winslow, PSC Kalamazoo, MI Alan M. Gewirtz, MD Louisville, KY Jason North University of Pennsylvania JSN Consulting William M. Ward, Jr. School of Medicine Secretary/Treasurer Palm Beach, FL Presbyterian Manors of Mid-America Philadelphia, PA Thomas L. Fitzpatrick Wichita, KS Mary J. Oyer Saint Gobain Corporation Carter K. D. Guice, Jr. Northfield, IL Robert M. Yacobi Worcester, MA Eastern District of Louisiana Williamsburg, VA New Orleans, LA Frederic C. Parvey Fidelity National Financial Steven L. Hooker Jacksonville, FL The Regence Group Portland, OR William H. Reimers Bowman Enterprises, Inc. Lynn C. Hoover Raleigh, NC Stinson Morrison Hecker, LLP Kansas City, MO Marcie Rehmar Rogell Children’s Hospital Thomas F. Hunter Columbus, OH Stimulys Carrollton, TX Naomi Rosenberg, PhD Tufts University School of Medicine Charles F. Inglefield Boston, MA Bay Village, OH 2 005 | AN N U AL R EPOR T

35 the leukemia & lymphoma society research foundation

Officers Medical Advisory Board

Harry Pearce • President Edward J. Benz, Jr., MD Of Counsel President Bowman and Brooke Dana-Farber Cancer Institute

John M. Kamins • Vice President Donald Pinkel, MD Partner San Luis Obis Co., CA Honigman Miller Schwartz and Cohn Louis W. Sullivan, MD Beverly S. Mitchell, MD • President Medical Vice President Morehouse School of Medicine Cancer Research Center Stanford University E. Donnall Thomas, MD Fred Hutchinson Cancer Dwayne Howell • Research Center Secretary-Treasurer Professor of Medicine, Emeritus President & Chief Executive Officer University of Washington The Leukemia & Lymphoma Society School of Medicine

Members

Alexandra Mayes Birnbaum Peartree Communications, Inc. senior staff Tom Bertelsen Dominican Sisters of San Rafael Dwayne Howell Marketing Communications President & Chief Executive Officer & Revenue Development Andrew Madoff Richard J. Geswell Bernard L. Madoff Investment Laurence W. Hausner Executive Vice President Securities Chief Operations Officer Revenue & Marketing Scott Zeilinger Field Management Nancy Klein Kadima Partners, LLC Cynthia Gardner Senior Vice President Executive Vice President Marketing Communications Field Management Greg Elfers Paul Weiss Senior Vice President Senior Vice President Campaign Development Field Management Patient Services Leslie Chambers Robin Kornhaber, MSW Senior Vice President Senior Vice President Field Management Patient Services Finance, Administration Research & Medical Programs & Information Technology Marshall A. Lichtman, MD John E. Walter Executive Vice President Executive Vice President Research & Medical Programs & Chief Financial Officer Finance, Administration Louis DeGennaro, PhD & Information Technology Senior Vice President Research Administration Jimmy Nangle Senior Vice President The Leukemia & Lymphoma Finance Society of Canada

Jon R. Lowell Rudy Putns Chief Information Officer Chief Executive Officer

Government & Legislative Affairs

George Dahlman Vice President Public Policy

Human Resources Development

Beverly Sherbondy Senior Vice President Human Resources

36 chapter offices Alphabetical by state

Alabama Suncoast Chapter Nevada Pennsylvania Gulf Coast Chapter 13907 North Dale Mabry Highway • Suite 101 Southern Nevada Chapter Central Pennsylvania Chapter 100 Chase Park South • Suite 220 Tampa, FL 33618 6280 South Valley View Boulevard • Suite 342 800 Corporate Circle • Suite 100 Birmingham, AL 35244 Telephone: 813.963.6461 Las Vegas, NV 89118 Harrisburg, PA 17110 Telephone: 205.989.0098 Telephone: 702.436.4220 Telephone: 717.652.6520 Georgia Arizona Georgia Chapter New Jersey Eastern Pennsylvania Chapter • Desert Mountain States Chapter 2625 Cumberland Parkway • Suite 205 Northern New Jersey Chapter #2 International Plaza Suite 245 Philadelphia, PA 19113 3877 North 7th Street • Suite 300 Atlanta, GA 30339 116 South Euclid Avenue Phoenix, AZ 85014 Telephone: 770.438.6006 Westfield, NJ 07090 Telephone: 610.521.8274 Telephone: 602.788.8622 Telephone: 908.654.9445 Greater Delaware Valley Division Illinois #2 International Plaza • Suite 105 California Illinois Chapter Southern New Jersey Shore Region Chapter • Philadelphia, PA 19113 Central California Chapter 651 West Washington Boulevard • Suite 400 216 Haddon Avenue Suite 328 Westmont, NJ 08108 Telephone: 610.521.8274 470 East Herndon • Suite 102 Chicago, IL 60661 Western Pennsylvania & West Virginia Chapter Fresno, CA 93720-2929 Telephone: 312.651.7350 Telephone: 856.869.0200 River Walk Corporate Centre • Suite 441 Telephone: 559.435.1482 Indiana New Mexico 333 East Carson Street Greater Los Angeles Chapter Indiana Chapter New Mexico/El Paso Chapter Pittsburgh, PA 15219 • • 6033 West Century Boulevard Suite 300 941 East 86th Street • Suite 100 3411 Candelaria NE Suite M Telephone: 412.395.2873 Los Angeles, CA 90045 Indianapolis, IN 46240 Albuquerque, NM 87107 Telephone: 310.216.7600 Telephone: 317.726.2270 Telephone: 505.872.0141 Rhode Island Greater Sacramento Area Chapter Rhode Island Chpater New York 1150 Pontiac Avenue • Suite 1 4604 Roseville Road • Suite 100 Iowa Iowa Chapter Central New York Chapter Cranston, RI 02920 North Highlands, CA 95660 Learbury Centre Telephone: 916.348.1793 8033 University Boulevard • Suite A Telephone: 401.943.8888 Des Moines, IA 50325 401 North Salina Street Greater San Francisco Bay Area Chapter Telephone: 515.270.6169 or 800.374.1074 Syracuse, NY 13203-1770 South Carolina 1390 Market Street • Suite 1200 Telephone: 315.471.1050 South Carolina Chapter San Francisco, CA 94102-5306 Kansas Long Island Chapter 1247 Lake Murray Boulevard Telephone: 415.625.1100 Kansas Chapter 555 Broad Hollow Road Irmo, SC 29063 Northern California Division 555 North Woodlawn Melville, NY 11747 Telephone: 803.749.4299 1390 Market Street • Suite 1200 Building 1 • Suite 113 Telephone: 631.752.8500 Wichita, KS 67208 Tennessee San Francisco, CA 94102-5306 New York City Chapter Tennessee Chapter Telephone: 415.625.1100 Telephone: 316.687.2222 475 Park Avenue South • 8th Floor 404 BNA Drive • Suite 102 Orange County Inland Empire Chapter Mid-America Chapter New York, NY 10016 Nashville, TN 37217 2020 East First Street • Suite 120 6811 West 63rd Street Telephone: 212.448.9206 Telephone: 615.331.2980 Santa Ana, CA 92705 Cloverleaf Building #1 • Suite 202 Shawnee Mission, KS 66202-4001 New York Metro Division Texas Telephone: 714.881.0610 • Telephone: 913.262.1515 205 Lexington Avenue 16th Floor North Texas Chapter San Diego/Hawaii Chapter New York, NY 10016 8111 LBJ Freeway • Suite 425 8575 Gibbs Drive • Suite 26.2 Kentucky Telephone: 212.689.1400 Dallas, TX 75251 San Diego, CA 92123 Kentucky & Southern Indiana Chapter Westchester/Hudson Valley Chapter Telephone: 972.239.0959 Telephone: 858.277.1800 600 East Main Street • Suite 102 1311 Mamaroneck Avenue • Suite 130 South Texas Chapter Silicon Valley & Monterey Bay Area Chapter Louisville, KY 40202-1077 White Plains, NY 10605 950 Isom Road • Suite 104 675 North First Street • Suite 1100 Telephone: 502.584.8490 Telephone: 914.949.0084 San Antonio, TX 78216 San Jose, CA 95112-5155 Louisiana Western New York & Finger Lakes Chapter Telephone: 210.377.1775 Telephone: 408.271.2873 Louisiana Chapter 4053 Maple Road Texas Gulf Coast Chapter Southern California Division Amherst, NY 14226 3636 South 1-10 Service Road • Suite 304 5005 Mitchelldale • Suite 115 6033 West Century Boulevard • Suite 300 Metairie, LA 70001 Telephone: 716.834.2578 Houston, TX 77092 Los Angeles, CA 90045 Telephone: 504.837.0945 Upstate New York/VT Chapter Telephone: 713.680.8088 Telephone: 310.216.7600 6 Automation Lane Maryland Virginia Colorado Albany, NY 12205 Maryland Chapter Virginia Chapter Rocky Mountain Chapter Telephone: 518.438.3583 11350 McCormick Road 5511 Staples Mill Road • Suite 202B 5353 West Dartmouth Avenue Executive Plaza lll • Suite 100 North Carolina Richmond, VA 23228 Denver, CO 80227 Hunt Valley, MD 21031 Eastern North Carolina Chapter Telephone: 804.627.0400 Telephone: 303.984.2110 Telephone: 410.527.0220 4320 Bland Road • Flagship Building Washington/Alaska Connecticut Raleigh, NC 27609 Massachusetts Washington/Alaska Chapter Connecticut Chapter Telephone: 919.875.8252 Massachusetts Chapter 530 Dexter Avenue North • Suite 300 300 Research Parkway • Suite 310 Western North Carolina Chapter 495 Old Connecticut Path • Suite 220 Seattle, WA 98109 Meriden, CT 06450 5950 Fairview Road • Suite 250 Framingham, MA 01701-4567 Telephone: 206.628.0777 Telephone: 203.379.0445 or 888.282.9464 Telephone: 508.879.5083 or 800.688.6572 Charlotte, NC 28210 Fairfield County CT Chapter Telephone: 704.998.5012 Washington, D.C. Michigan National Capital Chapter 25 Third Street • 4th Floor Ohio Stamford, CT 06905 Michigan Chapter 5845 Richmond Highway • Suite 800 1421 East Twelve Mile Road • Building A Central Ohio Chapter Telephone: 203.967.8326 Alexandria, VA 22303 2225 City Gate Drive • Suite E Madison Heights, MI 48071 Telephone: 703.960.1100 Delaware Telephone: 248.582.2900 Columbus, OH 43219 Delaware Chapter Telephone: 614.476.7194 Wisconsin Minnesota 100 West 10th Street • Suite 209 Northern Ohio Chapter Wisconsin Chapter Minnesota Chapter Wilmington, DE 19801 902 Westpoint Parkway • Suite 300 4125 North 124th Street • Unit A 8441 Wayzata Boulevard • Suite 340 Telephone: 302.661.7300 Cleveland, OH 44145 Brookfield, WI 53005 Golden Valley, MN 55426 Telephone: 440.617.2873 Telephone: 262.790.4701 Florida Telephone: 763.545.3309 Central Florida Chapter Southern Ohio Chapter

Mississippi 2300 Wall Street • Suite H 2 3319 Maguire Boulevard • Suite 101

Canadian Offices 005 Orlando, FL 32803 Mississippi Chapter Cincinnati, OH 45212 405 Fontaine Place • Suite 103 Greater Toronto Area Telephone: 407.898.0733 Telephone: 513.361.2100 Ridgeland, MS 39157 936 The East Mall

Northern Florida Chapter Telephone: 601.956.7447 Oklahoma Toronto, ON M9B 6J9 | 7077 Bonneval Road • Suite 610 Oklahoma Chapter Telephone: 416.661.2873 x107 AN Jacksonville, FL 32216 Missouri 500 North Broadway • Suite 250

Western Canada N Telephone: 904.332.6414 Gateway Chapter Oklahoma City, OK 73102 •

1682 West 7th Avenue Suite 310 U Palm Beach Chapter 77 West Port Plaza • Suite 101 Telephone: 405.943.8888 Vancouver, BC V6J 4S6 AL St. Louis, MO 63146-3111 4360 Northlake Boulevard • Suite 109 Telephone: 604.733.2873 Telephone: 314.878.0780 Oregon Palm Beach Gardens, FL 33410 Oregon Chapter R

Telephone: 561.775.9954 EPOR Nebraska 9320 SW Barbur Boulevard • Suite 140 Southern Florida Chapter Nebraska Chapter Portland, OR 97219 3325 Hollywood Boulevard • Suite 400 10832 Old Mill Road • Suite 200 Telephone: 503.245.9866

Hollywood, FL 33021 Omaha, NE 68154 T Telephone: 954.961.3234 Telephone: 402.344.2242 Photography: Christopher Spielmann The Society is a nonprofit organization that relies on the generosity of individual and corporate contributions to advance its mission. Call our Information Resource Center toll free at 800.955.4572 or visit www.LLS.org

1311 Mamaroneck Avenue White Plains, New York 10605 Telephone 914.949.5213 Facsimile 914.949.6691 www.LLS.org P001 20M 1/06